| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 2.54e-14 | 11 | 215 | 8 | GO:0098973 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | ACTBL2 SPTBN2 ACTB ACTG1 POTEKP ACTN1 POTEE POTEF PPFIA2 POTEJ POTEI | 5.57e-13 | 42 | 215 | 11 | GO:0098918 |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | ACTBL2 SPTBN2 ACTB ACTG1 POTEKP ACTN1 POTEE POTEF POTEJ POTEI | 8.91e-13 | 32 | 215 | 10 | GO:0099186 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | SPTA1 ACTBL2 SPTBN1 SPTBN2 ACTA1 ACTB ACTG1 POTEKP POTEE KRT19 POTEF LMNB2 MSN POTEJ POTEI | 1.05e-11 | 130 | 215 | 15 | GO:0005200 |
| GeneOntologyMolecularFunction | ATP-dependent activity | TDRD9 MYO7B DHX38 ACTB ACTC1 KATNAL1 DNAH14 MDN1 MYO3B DNAH5 HSP90AB1 MYO1H YTHDC2 CHD8 ATP9A RFC5 DNAH7 ABCC6 DNAH12 EIF4A2 SMARCA2 ATP1A4 | 8.75e-07 | 614 | 215 | 22 | GO:0140657 |
| GeneOntologyMolecularFunction | inositol-1,4,5-trisphosphate 3-kinase activity | 4.89e-06 | 4 | 215 | 3 | GO:0008440 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYO7B SPTA1 SPTBN1 SPTBN2 ACTA1 ACTB ACTC1 DAXX ACTN1 KATNAL1 EPB41L4A MAST2 TTBK2 CYFIP1 DST KCNE1 MYO3B CCSER2 DIAPH1 PLEKHH2 SETD3 RAB6A HSP90AB1 MYO1H RAB6B MSN CEP295 TRAK2 SNTB2 | 7.42e-06 | 1099 | 215 | 29 | GO:0008092 |
| GeneOntologyMolecularFunction | inositol tetrakisphosphate kinase activity | 1.21e-05 | 5 | 215 | 3 | GO:0051765 | |
| GeneOntologyMolecularFunction | inositol trisphosphate kinase activity | 1.21e-05 | 5 | 215 | 3 | GO:0051766 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | TDRD9 DHX38 ACTB KATNAL1 MDN1 DNAH5 HSP90AB1 YTHDC2 CHD8 ATP9A RFC5 DNAH7 ABCC6 DNAH12 EIF4A2 ATP1A4 | 2.48e-05 | 441 | 215 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.55e-05 | 18 | 215 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.21e-05 | 118 | 215 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | structural molecule activity | SPTA1 ACTBL2 SPTBN1 SPTBN2 ACTA1 ACTB EMILIN2 ACTG1 POTEKP ACTN1 POTEE DST KRT77 KRT4 KRT19 POTEF PPFIA2 LMNB2 KRT79 MSN POTEJ POTEI SNTB2 | 9.75e-05 | 891 | 215 | 23 | GO:0005198 |
| GeneOntologyMolecularFunction | inositol phosphate kinase activity | 1.91e-04 | 11 | 215 | 3 | GO:0180030 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.18e-04 | 28 | 215 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | phosphoserine residue binding | 2.52e-04 | 12 | 215 | 3 | GO:0050815 | |
| GeneOntologyMolecularFunction | profilin binding | 3.25e-04 | 13 | 215 | 3 | GO:0005522 | |
| GeneOntologyMolecularFunction | kinase binding | ACTBL2 ACTA2 ACTB FRS2 BARD1 ACTG1 DAXX NCK1 POTEKP STK11IP RYR2 POTEE SFN HSP90AB1 PRKD2 POTEF CIR1 TFRC MSN PRKCB POTEJ POTEI ATP1A4 | 3.28e-04 | 969 | 215 | 23 | GO:0019900 |
| GeneOntologyMolecularFunction | protein kinase binding | ACTBL2 ACTA2 ACTB FRS2 ACTG1 DAXX NCK1 POTEKP STK11IP RYR2 POTEE SFN HSP90AB1 PRKD2 POTEF CIR1 TFRC MSN PRKCB POTEJ POTEI | 5.06e-04 | 873 | 215 | 21 | GO:0019901 |
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 6.22e-04 | 16 | 215 | 3 | GO:0004697 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 6.53e-04 | 37 | 215 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | actin binding | MYO7B SPTA1 SPTBN1 SPTBN2 ACTN1 CYFIP1 DST MYO3B DIAPH1 PLEKHH2 SETD3 MYO1H MSN SNTB2 | 7.23e-04 | 479 | 215 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | microfilament motor activity | 7.24e-04 | 38 | 215 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | TDRD9 DHX38 ACTB KATNAL1 MDN1 DNAH5 RAB6A HSP90AB1 YTHDC2 CHD8 ATP9A RFC5 RAB6B DNAH7 ABCC6 RGS18 DNAH12 EIF4A2 ATP1A4 | 7.49e-04 | 775 | 215 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | SPTBN1 SPTBN2 CDH23 NCK1 ACTN1 ITGA9 ITGAE ITGB7 DST PLXNB3 SFN HSP90AB1 CIP2A YWHAB YWHAE MSN | 8.06e-04 | 599 | 215 | 16 | GO:0050839 |
| GeneOntologyMolecularFunction | alcohol binding | 8.29e-04 | 102 | 215 | 6 | GO:0043178 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | MYCBP2 ARHGEF9 DOCK6 DOCK2 ARHGEF28 KALRN ARHGEF25 PLEKHG4B RAPGEFL1 | 9.26e-04 | 231 | 215 | 9 | GO:0005085 |
| GeneOntologyMolecularFunction | GABA receptor binding | 1.23e-03 | 20 | 215 | 3 | GO:0050811 | |
| GeneOntologyMolecularFunction | helicase activity | 1.65e-03 | 158 | 215 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | 3'-5' RNA helicase activity | 1.68e-03 | 6 | 215 | 2 | GO:0034458 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | TDRD9 DHX38 ACTB KATNAL1 MDN1 DNAH5 RAB6A HSP90AB1 YTHDC2 CHD8 ATP9A RFC5 RAB6B DNAH7 ABCC6 RGS18 DNAH12 EIF4A2 ATP1A4 | 1.88e-03 | 839 | 215 | 19 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | TDRD9 DHX38 ACTB KATNAL1 MDN1 DNAH5 RAB6A HSP90AB1 YTHDC2 CHD8 ATP9A RFC5 RAB6B DNAH7 ABCC6 RGS18 DNAH12 EIF4A2 ATP1A4 | 1.90e-03 | 840 | 215 | 19 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | TDRD9 DHX38 ACTB KATNAL1 MDN1 DNAH5 RAB6A HSP90AB1 YTHDC2 CHD8 ATP9A RFC5 RAB6B DNAH7 ABCC6 RGS18 DNAH12 EIF4A2 ATP1A4 | 1.90e-03 | 840 | 215 | 19 | GO:0016818 |
| GeneOntologyMolecularFunction | myosin binding | 2.25e-03 | 85 | 215 | 5 | GO:0017022 | |
| GeneOntologyMolecularFunction | kinesin binding | 2.90e-03 | 55 | 215 | 4 | GO:0019894 | |
| GeneOntologyMolecularFunction | TPR domain binding | 3.10e-03 | 8 | 215 | 2 | GO:0030911 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 6.52e-10 | 31 | 210 | 8 | GO:0098974 | |
| GeneOntologyBiologicalProcess | actin filament-based process | MYO7B SPTA1 ACTBL2 SPTBN1 SPTBN2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 NCK1 POTEKP ACTN1 EPB41L4A RYR2 ITPKA POTEE FAT1 CYFIP1 KCNE1 MYO3B SCN8A DIAPH1 PLEKHH2 SETD3 DOCK2 KRT19 POTEF MYO1H POTEJ POTEI RNF207 | 9.29e-10 | 912 | 210 | 32 | GO:0030029 |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 1.88e-09 | 35 | 210 | 8 | GO:0099188 | |
| GeneOntologyBiologicalProcess | mesenchyme migration | 5.18e-08 | 5 | 210 | 4 | GO:0090131 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYO7B SPTA1 ACTBL2 SPTBN1 SPTBN2 ACTA1 ACTB ACTC1 ACTG1 NCK1 POTEKP ACTN1 EPB41L4A ITPKA POTEE FAT1 CYFIP1 MYO3B DIAPH1 PLEKHH2 SETD3 DOCK2 KRT19 POTEF MYO1H POTEJ POTEI | 5.25e-08 | 803 | 210 | 27 | GO:0030036 |
| GeneOntologyBiologicalProcess | postsynapse organization | ACTBL2 SPTBN2 ACTB ACTG1 POTEKP ACTN1 ITPKA POTEE ARHGEF9 KALRN POTEF PPFIA2 GRID2 RPH3A POTEJ POTEI | 1.45e-07 | 313 | 210 | 16 | GO:0099173 |
| GeneOntologyBiologicalProcess | neuron development | KREMEN1 MYCBP2 ACTBL2 ACTB ACTG1 CDH23 NCK1 POTEKP ITPKA POTEE FBXW8 CYFIP1 DST SEMA6D MYO3B DIAPH1 MINAR1 RAB6A PLXNB3 ANKS1A ARHGEF28 KALRN POTEF PPFIA2 GRID2 ATP9A ARHGEF25 RAB6B PLEKHG4B THRB PPT1 ST8SIA2 MTR TRAK2 POTEJ POTEI GABRA5 | 2.38e-07 | 1463 | 210 | 37 | GO:0048666 |
| GeneOntologyBiologicalProcess | synapse organization | MYCBP2 ACTBL2 PCDHB5 SPTBN2 ACTB ACTG1 POTEKP ACTN1 ITPKA POTEE CYFIP1 ARHGEF9 KALRN POTEF PPFIA2 PCDHB9 GRID2 PPFIA3 RPH3A ST8SIA2 POTEJ POTEI GABRA5 | 5.66e-07 | 685 | 210 | 23 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | MYCBP2 ACTBL2 ACTB ACTG1 CDH23 POTEKP ITPKA POTEE FBXW8 CYFIP1 DST SEMA6D MYO3B DIAPH1 PLXNB3 ARHGEF28 KALRN POTEF PPFIA2 ARHGEF25 PLEKHG4B TRAK2 POTEJ POTEI | 7.11e-07 | 748 | 210 | 24 | GO:0048667 |
| GeneOntologyBiologicalProcess | neuron projection development | KREMEN1 MYCBP2 ACTBL2 ACTB ACTG1 CDH23 NCK1 POTEKP ITPKA POTEE FBXW8 CYFIP1 DST SEMA6D MYO3B DIAPH1 MINAR1 RAB6A PLXNB3 ARHGEF28 KALRN POTEF PPFIA2 GRID2 ATP9A ARHGEF25 RAB6B PLEKHG4B ST8SIA2 MTR TRAK2 POTEJ POTEI | 8.40e-07 | 1285 | 210 | 33 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis | MYCBP2 SPTA1 ACTBL2 ACTB ACTG1 CDH23 POTEKP ACTN1 STRIP2 ITPKA POTEE FBXW8 FAT1 CYFIP1 DST SEMA6D MYO3B DIAPH1 PLXNB3 ARHGEF28 KALRN POTEF PPFIA2 ATP9A ARHGEF25 MSN PLEKHG4B ST8SIA2 TRAK2 POTEJ POTEI | 1.51e-06 | 1194 | 210 | 31 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | MYCBP2 ACTBL2 ACTB ACTG1 POTEKP ITPKA POTEE FBXW8 CYFIP1 DST SEMA6D DIAPH1 PLXNB3 ARHGEF28 KALRN POTEF PPFIA2 ATP9A ARHGEF25 PLEKHG4B ST8SIA2 TRAK2 POTEJ POTEI | 2.40e-06 | 802 | 210 | 24 | GO:0048812 |
| GeneOntologyBiologicalProcess | axon development | KREMEN1 MYCBP2 ACTBL2 ACTB ACTG1 POTEKP POTEE CYFIP1 DST SEMA6D DIAPH1 PLXNB3 ARHGEF28 KALRN POTEF ARHGEF25 PLEKHG4B MTR TRAK2 POTEJ POTEI | 2.73e-06 | 642 | 210 | 21 | GO:0061564 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | MYCBP2 ACTBL2 ACTB ACTG1 POTEKP ITPKA POTEE FBXW8 CYFIP1 DST SEMA6D DIAPH1 PLXNB3 ARHGEF28 KALRN POTEF PPFIA2 ATP9A ARHGEF25 PLEKHG4B ST8SIA2 TRAK2 POTEJ POTEI | 3.44e-06 | 819 | 210 | 24 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | MYCBP2 ACTBL2 ACTB ACTG1 POTEKP ITPKA POTEE FBXW8 CYFIP1 DST SEMA6D DIAPH1 PLXNB3 ARHGEF28 KALRN POTEF PPFIA2 ATP9A ARHGEF25 PLEKHG4B ST8SIA2 TRAK2 POTEJ POTEI | 3.98e-06 | 826 | 210 | 24 | GO:0048858 |
| GeneOntologyBiologicalProcess | axonogenesis | MYCBP2 ACTBL2 ACTB ACTG1 POTEKP POTEE CYFIP1 DST SEMA6D DIAPH1 PLXNB3 ARHGEF28 KALRN POTEF ARHGEF25 PLEKHG4B TRAK2 POTEJ POTEI | 5.76e-06 | 566 | 210 | 19 | GO:0007409 |
| GeneOntologyBiologicalProcess | positive regulation of centrosome duplication | 2.03e-05 | 6 | 210 | 3 | GO:0010825 | |
| GeneOntologyBiologicalProcess | cell junction organization | MYCBP2 HIPK1 ACTBL2 PCDHB5 SPTBN2 ACTB ACTG1 POTEKP ACTN1 ITPKA POTEE CYFIP1 DST ARHGEF9 KALRN POTEF PPFIA2 PCDHB9 GRID2 PPFIA3 RPH3A ST8SIA2 POTEJ POTEI GABRA5 | 2.08e-05 | 974 | 210 | 25 | GO:0034330 |
| GeneOntologyBiologicalProcess | post-Golgi vesicle-mediated transport | 3.01e-05 | 119 | 210 | 8 | GO:0006892 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 7.37e-05 | 100 | 210 | 7 | GO:0045103 | |
| GeneOntologyBiologicalProcess | synaptic vesicle cycle | SPTBN2 ACTB ACTG1 SNAP29 CYFIP1 DIAPH1 PPFIA2 PPFIA3 RPH3A PRKCB PRKCG | 8.76e-05 | 264 | 210 | 11 | GO:0099504 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MYO7B SPTA1 SPTBN1 SPTBN2 ACTA1 ACTC1 ACTG1 NCK1 ACTN1 KATNAL1 TTBK2 FAT1 CYFIP1 CEP120 KRT77 DIAPH1 PLEKHH2 HSP90AB1 KRT4 KRT19 MYO1H KRT79 PDE4DIP | 1.22e-04 | 957 | 210 | 23 | GO:0097435 |
| GeneOntologyBiologicalProcess | cytosolic transport | 1.54e-04 | 150 | 210 | 8 | GO:0016482 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.77e-04 | 153 | 210 | 8 | GO:0030048 | |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 2.20e-04 | 54 | 210 | 5 | GO:0048013 | |
| GeneOntologyBiologicalProcess | synaptic vesicle exocytosis | 2.97e-04 | 125 | 210 | 7 | GO:0016079 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | HIPK1 RPS6KA1 NCK1 MAST2 TTBK2 MYO3B PRKD2 NSD1 TFRC PRKCB PRKCG | 3.25e-04 | 307 | 210 | 11 | GO:0018105 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYO7B SPTA1 ACTBL2 SPTBN1 SPTBN2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP ACTN1 ITPKA POTEE DST MYO3B DIAPH1 PLEKHH2 KALRN KRT19 POTEF MYO1H ANKRD62 PRKCB POTEJ POTEI | 4.75e-11 | 576 | 214 | 27 | GO:0015629 |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 9.01e-10 | 32 | 214 | 8 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 9.01e-10 | 32 | 214 | 8 | GO:0043189 | |
| GeneOntologyCellularComponent | supramolecular fiber | ACTBL2 SPTBN1 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 DAXX SYNC POTEKP ACTN1 KATNAL1 DNAH14 RYR2 POTEE DST GRK3 KCNE1 KRT77 SCN8A DIAPH1 DNAH5 KRT4 KRT19 POTEF LMNB2 ARHGEF25 KRT79 DNAH7 DNAH12 PDE4DIP CEP295 POTEJ POTEI SNTB2 | 3.64e-09 | 1179 | 214 | 36 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | ACTBL2 SPTBN1 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 DAXX SYNC POTEKP ACTN1 KATNAL1 DNAH14 RYR2 POTEE DST GRK3 KCNE1 KRT77 SCN8A DIAPH1 DNAH5 KRT4 KRT19 POTEF LMNB2 ARHGEF25 KRT79 DNAH7 DNAH12 PDE4DIP CEP295 POTEJ POTEI SNTB2 | 4.35e-09 | 1187 | 214 | 36 | GO:0099081 |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 1.65e-08 | 45 | 214 | 8 | GO:1902562 | |
| GeneOntologyCellularComponent | actin filament | ACTBL2 ACTA1 ACTB ACTC1 ACTG1 POTEKP ACTN1 POTEE DIAPH1 POTEF POTEJ POTEI | 3.60e-08 | 146 | 214 | 12 | GO:0005884 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | ACTBL2 ACTA1 ACTB ACTC1 ACTG1 DAXX SYNC POTEKP ACTN1 KATNAL1 DNAH14 POTEE DST KRT77 DIAPH1 DNAH5 KRT4 KRT19 POTEF LMNB2 KRT79 DNAH7 DNAH12 PDE4DIP CEP295 POTEJ POTEI SNTB2 | 1.62e-07 | 899 | 214 | 28 | GO:0099513 |
| GeneOntologyCellularComponent | contractile muscle fiber | SPTBN1 ACTA1 ACTA2 ACTC1 ACTG1 SYNC ACTN1 RYR2 DST GRK3 KCNE1 SCN8A KRT19 ARHGEF25 PDE4DIP | 3.34e-07 | 290 | 214 | 15 | GO:0043292 |
| GeneOntologyCellularComponent | myofibril | SPTBN1 ACTA1 ACTC1 ACTG1 SYNC ACTN1 RYR2 DST GRK3 KCNE1 SCN8A KRT19 ARHGEF25 PDE4DIP | 9.22e-07 | 273 | 214 | 14 | GO:0030016 |
| GeneOntologyCellularComponent | spectrin | 1.29e-06 | 9 | 214 | 4 | GO:0008091 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 5.54e-06 | 94 | 214 | 8 | GO:0000123 | |
| GeneOntologyCellularComponent | cell cortex | SPTA1 SPTBN1 SPTBN2 ACTB DAXX ACTN1 DST ARHGEF9 PLEKHH2 KRT19 POTEF PPFIA3 EXOC5 PDE4DIP PRKCB | 7.05e-06 | 371 | 214 | 15 | GO:0005938 |
| GeneOntologyCellularComponent | cortical cytoskeleton | 7.40e-06 | 129 | 214 | 9 | GO:0030863 | |
| GeneOntologyCellularComponent | sarcomere | SPTBN1 ACTA1 ACTC1 SYNC ACTN1 RYR2 DST GRK3 KCNE1 SCN8A KRT19 ARHGEF25 | 1.05e-05 | 249 | 214 | 12 | GO:0030017 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | CALCOCO2 SPTBN2 SYNC LAPTM5 FBXW8 FAT1 CYFIP1 DST GRK3 UBR5 OSBPL1A DOCK6 HSP90AB1 KALRN YTHDC2 ATP9A YWHAB TFRC MSN LNPEP EIF4A2 ST8SIA2 PRKCG ROS1 RNF207 | 1.14e-05 | 934 | 214 | 25 | GO:0048471 |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.17e-05 | 104 | 214 | 8 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.66e-05 | 109 | 214 | 8 | GO:1902493 | |
| GeneOntologyCellularComponent | blood microparticle | 1.80e-05 | 144 | 214 | 9 | GO:0072562 | |
| GeneOntologyCellularComponent | actin-based cell projection | MYO7B PDZK1 ACTA1 ACTA2 ACTC1 CDH23 ACTG2 FAT1 CYFIP1 MYO3B MYO1H MSN | 3.14e-05 | 278 | 214 | 12 | GO:0098858 |
| GeneOntologyCellularComponent | filopodium | 3.98e-05 | 123 | 214 | 8 | GO:0030175 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 4.80e-05 | 93 | 214 | 7 | GO:0030864 | |
| GeneOntologyCellularComponent | I band | 5.52e-05 | 166 | 214 | 9 | GO:0031674 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 8.49e-05 | 9 | 214 | 3 | GO:0014731 | |
| GeneOntologyCellularComponent | axon | MYCBP2 SPTA1 ACTBL2 SPTBN1 ACTB ACTG1 POTEKP POTEE CYFIP1 DST GRK3 SCN8A HSP90AB1 POTEF PPFIA2 YWHAE PPT1 PRKCB PRKCG TRAK2 POTEJ POTEI | 1.28e-04 | 891 | 214 | 22 | GO:0030424 |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 1.34e-04 | 26 | 214 | 4 | GO:0099571 | |
| GeneOntologyCellularComponent | Z disc | 1.68e-04 | 151 | 214 | 8 | GO:0030018 | |
| GeneOntologyCellularComponent | calyx of Held | 4.87e-04 | 36 | 214 | 4 | GO:0044305 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 5.05e-04 | 223 | 214 | 9 | GO:0098862 | |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 9.08e-04 | 19 | 214 | 3 | GO:0098871 | |
| GeneOntologyCellularComponent | brush border | 9.87e-04 | 152 | 214 | 7 | GO:0005903 | |
| GeneOntologyCellularComponent | dendrite terminus | 1.06e-03 | 20 | 214 | 3 | GO:0044292 | |
| GeneOntologyCellularComponent | presynaptic cytosol | 1.58e-03 | 49 | 214 | 4 | GO:0099523 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 1.61e-03 | 263 | 214 | 9 | GO:0045111 | |
| GeneOntologyCellularComponent | focal adhesion | ACTB ACTC1 ACTG1 ACTN1 ITGB7 FAT1 CYFIP1 DST YWHAB YWHAE MSN SNTB2 | 1.69e-03 | 431 | 214 | 12 | GO:0005925 |
| GeneOntologyCellularComponent | cell leading edge | SPTBN1 ACTA1 ACTA2 ACTB ACTC1 ACTG2 ACTN1 FAT1 CYFIP1 DST DIAPH1 PLEKHH2 GABRA5 | 2.02e-03 | 500 | 214 | 13 | GO:0031252 |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.06e-03 | 25 | 214 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | central region of growth cone | 2.12e-03 | 7 | 214 | 2 | GO:0090724 | |
| GeneOntologyCellularComponent | dense body | 2.12e-03 | 7 | 214 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | cell-substrate junction | ACTB ACTC1 ACTG1 ACTN1 ITGB7 FAT1 CYFIP1 DST YWHAB YWHAE MSN SNTB2 | 2.13e-03 | 443 | 214 | 12 | GO:0030055 |
| GeneOntologyCellularComponent | dynein complex | 2.26e-03 | 54 | 214 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | anchoring junction | PCDHB5 SPTBN2 ACTB FRS2 ACTC1 ACTG1 NCK1 ACTN1 MAST2 ITGB7 FAT1 CYFIP1 DST SLC31A1 YWHAB YWHAE MSN PLEKHG4B PRKCG SNTB2 | 2.55e-03 | 976 | 214 | 20 | GO:0070161 |
| GeneOntologyCellularComponent | lamellipodium | 2.62e-03 | 230 | 214 | 8 | GO:0030027 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 3.13e-03 | 59 | 214 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 3.23e-03 | 238 | 214 | 8 | GO:0097729 | |
| GeneOntologyCellularComponent | integrin complex | 4.22e-03 | 32 | 214 | 3 | GO:0008305 | |
| GeneOntologyCellularComponent | inner dynein arm | 4.45e-03 | 10 | 214 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | bBAF complex | 4.45e-03 | 10 | 214 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | presynapse | SPTBN2 ACTB ACTG1 SNAP29 CYFIP1 GRK3 SCN8A DIAPH1 RAB6A KALRN PPFIA2 PPFIA3 RAB6B RPH3A PPT1 PRKCB PRKCG GABRA5 | 4.53e-03 | 886 | 214 | 18 | GO:0098793 |
| GeneOntologyCellularComponent | contractile actin filament bundle | 4.90e-03 | 107 | 214 | 5 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 4.90e-03 | 107 | 214 | 5 | GO:0001725 | |
| Domain | Actin_CS | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEE POTEF POTEJ POTEI | 1.29e-18 | 16 | 212 | 11 | IPR004001 |
| Domain | ACTINS_2 | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEE POTEF POTEJ POTEI | 3.62e-18 | 17 | 212 | 11 | PS00432 |
| Domain | Actin/actin-like_CS | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEE POTEF POTEJ POTEI | 9.22e-18 | 18 | 212 | 11 | IPR020902 |
| Domain | ACTINS_ACT_LIKE | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEE POTEF POTEJ POTEI | 2.17e-17 | 19 | 212 | 11 | PS01132 |
| Domain | Actin | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEE POTEF POTEJ POTEI | 2.16e-14 | 31 | 212 | 11 | IPR004000 |
| Domain | Actin | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEE POTEF POTEJ POTEI | 2.16e-14 | 31 | 212 | 11 | PF00022 |
| Domain | ACTIN | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEE POTEF POTEJ POTEI | 2.16e-14 | 31 | 212 | 11 | SM00268 |
| Domain | ACTINS_1 | 1.74e-13 | 8 | 212 | 7 | PS00406 | |
| Domain | PH_dom-like | MYO7B SPTBN1 SPTBN2 FRS2 EPB41L4A AFAP1L2 GRK3 ARHGEF9 OSBPL1A OSBPL5 PLCL1 PLEKHH2 ANKS1A PRKD2 ARHGEF28 KALRN ARHGEF25 MSN PLEKHG4B PPP4R3B PLCH2 DGKK SNTB2 | 6.55e-10 | 426 | 212 | 23 | IPR011993 |
| Domain | - | MYO7B SPTBN1 SPTBN2 FRS2 EPB41L4A AFAP1L2 GRK3 ARHGEF9 OSBPL1A OSBPL5 PLCL1 PLEKHH2 ANKS1A PRKD2 ARHGEF28 KALRN ARHGEF25 MSN PLEKHG4B PPP4R3B PLCH2 DGKK | 7.31e-10 | 391 | 212 | 22 | 2.30.29.30 |
| Domain | PH | SPTBN1 SPTBN2 AFAP1L2 GRK3 ARHGEF9 OSBPL1A OSBPL5 PLCL1 PLEKHH2 PRKD2 ARHGEF28 KALRN ARHGEF25 PLEKHG4B PLCH2 DGKK SNTB2 | 2.03e-08 | 278 | 212 | 17 | SM00233 |
| Domain | PH_DOMAIN | SPTBN1 SPTBN2 AFAP1L2 GRK3 ARHGEF9 OSBPL1A OSBPL5 PLCL1 PLEKHH2 PRKD2 ARHGEF28 KALRN ARHGEF25 PLEKHG4B PLCH2 DGKK SNTB2 | 2.14e-08 | 279 | 212 | 17 | PS50003 |
| Domain | PH_domain | SPTBN1 SPTBN2 AFAP1L2 GRK3 ARHGEF9 OSBPL1A OSBPL5 PLCL1 PLEKHH2 PRKD2 ARHGEF28 KALRN ARHGEF25 PLEKHG4B PLCH2 DGKK SNTB2 | 2.25e-08 | 280 | 212 | 17 | IPR001849 |
| Domain | Spectrin_repeat | 2.78e-08 | 29 | 212 | 7 | IPR002017 | |
| Domain | SPEC | 5.82e-08 | 32 | 212 | 7 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 5.82e-08 | 32 | 212 | 7 | IPR018159 | |
| Domain | Spectrin | 1.71e-07 | 23 | 212 | 6 | PF00435 | |
| Domain | PH | SPTBN1 SPTBN2 AFAP1L2 GRK3 ARHGEF9 OSBPL5 PLEKHH2 PRKD2 KALRN PLCH2 DGKK SNTB2 | 1.26e-05 | 229 | 212 | 12 | PF00169 |
| Domain | Dynein_heavy_chain_D4_dom | 1.48e-05 | 14 | 212 | 4 | IPR024317 | |
| Domain | AAA_8 | 1.48e-05 | 14 | 212 | 4 | PF12780 | |
| Domain | DHC_fam | 2.00e-05 | 15 | 212 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 2.00e-05 | 15 | 212 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.00e-05 | 15 | 212 | 4 | IPR004273 | |
| Domain | 14_3_3 | 4.88e-05 | 7 | 212 | 3 | SM00101 | |
| Domain | 1433_1 | 4.88e-05 | 7 | 212 | 3 | PS00796 | |
| Domain | 1433_2 | 4.88e-05 | 7 | 212 | 3 | PS00797 | |
| Domain | 14-3-3_domain | 4.88e-05 | 7 | 212 | 3 | IPR023410 | |
| Domain | 14-3-3_CS | 4.88e-05 | 7 | 212 | 3 | IPR023409 | |
| Domain | 14-3-3 | 4.88e-05 | 7 | 212 | 3 | PF00244 | |
| Domain | IPK | 4.88e-05 | 7 | 212 | 3 | PF03770 | |
| Domain | IPK | 4.88e-05 | 7 | 212 | 3 | IPR005522 | |
| Domain | 14-3-3 | 7.74e-05 | 8 | 212 | 3 | IPR000308 | |
| Domain | ACTININ_2 | 1.21e-04 | 23 | 212 | 4 | PS00020 | |
| Domain | ACTININ_1 | 1.21e-04 | 23 | 212 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.21e-04 | 23 | 212 | 4 | IPR001589 | |
| Domain | Dopey_N | 1.28e-04 | 2 | 212 | 2 | PF04118 | |
| Domain | Dopey_N | 1.28e-04 | 2 | 212 | 2 | IPR007249 | |
| Domain | IF | 1.67e-04 | 72 | 212 | 6 | PS00226 | |
| Domain | Filament | 1.80e-04 | 73 | 212 | 6 | PF00038 | |
| Domain | IF | 2.25e-04 | 76 | 212 | 6 | IPR001664 | |
| Domain | - | TDRD9 MYO7B SPEF2 DHX38 CARD10 KATNAL1 DNAH14 MDN1 DNAH5 RAB6A YTHDC2 CHD8 RFC5 RAB6B DNAH7 ABCC6 DNAH12 GIMAP8 EIF4A2 SMARCA2 | 3.39e-04 | 746 | 212 | 20 | 3.40.50.300 |
| Domain | Protein_kinase_C_a/b/g | 3.82e-04 | 3 | 212 | 2 | IPR014375 | |
| Domain | AGC-kinase_C | 4.29e-04 | 56 | 212 | 5 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 4.29e-04 | 56 | 212 | 5 | PS51285 | |
| Domain | S_TK_X | 4.29e-04 | 56 | 212 | 5 | SM00133 | |
| Domain | C1_1 | 4.66e-04 | 57 | 212 | 5 | PF00130 | |
| Domain | Dynein_HC_stalk | 4.79e-04 | 14 | 212 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.79e-04 | 14 | 212 | 3 | IPR013602 | |
| Domain | DHC_N2 | 4.79e-04 | 14 | 212 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.79e-04 | 14 | 212 | 3 | IPR011704 | |
| Domain | MT | 4.79e-04 | 14 | 212 | 3 | PF12777 | |
| Domain | AAA_5 | 4.79e-04 | 14 | 212 | 3 | PF07728 | |
| Domain | - | ANKRD49 BARD1 POTEE OSBPL1A ANKS1A POTEF ANKRD62 YTHDC2 POTEJ POTEI | 5.58e-04 | 248 | 212 | 10 | 1.25.40.20 |
| Domain | ANK | ANKRD49 BARD1 POTEE OSBPL1A ANKS1A POTEF ANKRD62 YTHDC2 POTEJ POTEI | 6.12e-04 | 251 | 212 | 10 | SM00248 |
| Domain | ANK_REPEAT | ANKRD49 BARD1 POTEE OSBPL1A ANKS1A POTEF ANKRD62 YTHDC2 POTEJ POTEI | 6.51e-04 | 253 | 212 | 10 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | ANKRD49 BARD1 POTEE OSBPL1A ANKS1A POTEF ANKRD62 YTHDC2 POTEJ POTEI | 6.71e-04 | 254 | 212 | 10 | IPR020683 |
| Domain | ANK_REP_REGION | ANKRD49 BARD1 POTEE OSBPL1A ANKS1A POTEF ANKRD62 YTHDC2 POTEJ POTEI | 6.71e-04 | 254 | 212 | 10 | PS50297 |
| Domain | P-loop_NTPase | TDRD9 MYO7B SPEF2 DHX38 CARD10 KATNAL1 DNAH14 MDN1 MYO3B DNAH5 RAB6A YTHDC2 CHD8 RFC5 RAB6B DNAH7 ABCC6 DNAH12 GIMAP8 EIF4A2 SMARCA2 | 6.80e-04 | 848 | 212 | 21 | IPR027417 |
| Domain | Intermediate_filament_CS | 7.40e-04 | 63 | 212 | 5 | IPR018039 | |
| Domain | DH_1 | 7.40e-04 | 63 | 212 | 5 | PS00741 | |
| Domain | Spectrin_bsu | 7.58e-04 | 4 | 212 | 2 | IPR016343 | |
| Domain | ZF_DAG_PE_1 | 7.96e-04 | 64 | 212 | 5 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 7.96e-04 | 64 | 212 | 5 | PS50081 | |
| Domain | Ankyrin_rpt | ANKRD49 BARD1 POTEE OSBPL1A ANKS1A POTEF ANKRD62 YTHDC2 POTEJ POTEI | 8.51e-04 | 262 | 212 | 10 | IPR002110 |
| Domain | C1 | 8.54e-04 | 65 | 212 | 5 | SM00109 | |
| Domain | PE/DAG-bd | 9.16e-04 | 66 | 212 | 5 | IPR002219 | |
| Domain | HA2 | 1.04e-03 | 18 | 212 | 3 | SM00847 | |
| Domain | HA2 | 1.04e-03 | 18 | 212 | 3 | PF04408 | |
| Domain | Helicase-assoc_dom | 1.04e-03 | 18 | 212 | 3 | IPR007502 | |
| Domain | RhoGEF | 1.05e-03 | 68 | 212 | 5 | SM00325 | |
| Domain | RhoGEF | 1.20e-03 | 70 | 212 | 5 | PF00621 | |
| Domain | DH_2 | 1.20e-03 | 70 | 212 | 5 | PS50010 | |
| Domain | Ank | ANKRD49 BARD1 POTEE OSBPL1A ANKS1A POTEF ANKRD62 POTEJ POTEI | 1.22e-03 | 228 | 212 | 9 | PF00023 |
| Domain | CIDE-N_dom | 1.25e-03 | 5 | 212 | 2 | IPR003508 | |
| Domain | CIDE_N | 1.25e-03 | 5 | 212 | 2 | PS51135 | |
| Domain | CIDE-N | 1.25e-03 | 5 | 212 | 2 | PF02017 | |
| Domain | CAD | 1.25e-03 | 5 | 212 | 2 | SM00266 | |
| Domain | - | 1.27e-03 | 71 | 212 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 1.27e-03 | 71 | 212 | 5 | IPR000219 | |
| Domain | Filament | 1.27e-03 | 71 | 212 | 5 | SM01391 | |
| Domain | Pkinase_C | 1.29e-03 | 42 | 212 | 4 | PF00433 | |
| Domain | AAA | 1.30e-03 | 144 | 212 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 1.30e-03 | 144 | 212 | 7 | IPR003593 | |
| Domain | Prefoldin | 1.36e-03 | 72 | 212 | 5 | IPR009053 | |
| Domain | Helicase_C | 1.39e-03 | 107 | 212 | 6 | PF00271 | |
| Domain | HELICc | 1.39e-03 | 107 | 212 | 6 | SM00490 | |
| Domain | CH | 1.44e-03 | 73 | 212 | 5 | PS50021 | |
| Domain | Helicase_C | 1.46e-03 | 108 | 212 | 6 | IPR001650 | |
| Domain | HELICASE_CTER | 1.53e-03 | 109 | 212 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.53e-03 | 109 | 212 | 6 | PS51192 | |
| Domain | DEXDc | 1.53e-03 | 109 | 212 | 6 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.60e-03 | 110 | 212 | 6 | IPR014001 | |
| Domain | CH-domain | 1.63e-03 | 75 | 212 | 5 | IPR001715 | |
| Domain | DAG/PE-bd | 1.65e-03 | 21 | 212 | 3 | IPR020454 | |
| Domain | FERM_M | 1.81e-03 | 46 | 212 | 4 | PF00373 | |
| Domain | BRK | 1.87e-03 | 6 | 212 | 2 | SM00592 | |
| Domain | BRK_domain | 1.87e-03 | 6 | 212 | 2 | IPR006576 | |
| Domain | EFhand_Ca_insen | 1.87e-03 | 6 | 212 | 2 | PF08726 | |
| Domain | EF-hand_Ca_insen | 1.87e-03 | 6 | 212 | 2 | IPR014837 | |
| Domain | Liprin | 1.87e-03 | 6 | 212 | 2 | IPR029515 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | SPTBN1 ACTB FRS2 ACTC1 ACTG1 NCK1 ACTN1 SHKBP1 POTEE CYFIP1 DST ARHGEF9 DIAPH1 DOCK6 FAM135A HSP90AB1 DOCK2 ARHGEF28 KALRN ARHGEF25 TFRC PLEKHG4B MTR | 1.44e-09 | 450 | 160 | 23 | M27078 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | CENPN SPTBN1 ACTB FRS2 ACTC1 ACTG1 NCK1 ACTN1 SHKBP1 POTEE CYFIP1 DST ARHGEF9 DIAPH1 DOCK6 FAM135A SFN HSP90AB1 DOCK2 ARHGEF28 KALRN ARHGEF25 YWHAB YWHAE TFRC PLEKHG4B MTR PRKCB TRAK2 | 2.15e-09 | 720 | 160 | 29 | M41838 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | CENPN SPTBN1 ACTB FRS2 ACTC1 ACTG1 NCK1 ACTN1 CYFIP1 DST ARHGEF9 DIAPH1 DOCK6 FAM135A SFN HSP90AB1 DOCK2 ARHGEF28 KALRN ANKRD62 ARHGEF25 YWHAB YWHAE TFRC MTR PRKCB TRAK2 | 4.21e-09 | 649 | 160 | 27 | MM15690 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | SPTBN1 ACTB FRS2 ACTC1 ACTG1 NCK1 ACTN1 CYFIP1 DST ARHGEF9 DIAPH1 DOCK6 FAM135A HSP90AB1 DOCK2 ARHGEF28 KALRN ANKRD62 ARHGEF25 TFRC MTR | 2.52e-08 | 439 | 160 | 21 | MM15595 |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 4.26e-08 | 10 | 160 | 5 | MM15112 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | ACTA1 ACTA2 ACTB ACTC1 ACTG1 RYR2 SFN YWHAB YWHAE RGS18 PRKCB PRKCG | 2.08e-07 | 156 | 160 | 12 | M39475 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | SPTA1 SPTBN1 SPTBN2 ACTB FRS2 ACTG1 NCK1 ITGA9 SEMA6D PLXNB3 HSP90AB1 ARHGEF28 KALRN MSN ST8SIA2 | 2.82e-07 | 261 | 160 | 15 | MM15676 |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 9.14e-07 | 47 | 160 | 7 | M39829 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | RPS6KA1 SPTA1 SPTBN1 SPTBN2 ACTB FRS2 ACTG1 NCK1 ITGA9 SEMA6D KRT77 PLXNB3 HSP90AB1 KRT4 ARHGEF28 KALRN KRT19 KRT79 MSN ST8SIA2 | 1.04e-06 | 502 | 160 | 20 | MM14537 |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.13e-06 | 31 | 160 | 6 | M877 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | ACTA1 ACTB ACTC1 ACTG1 RYR2 SFN YWHAB YWHAE RGS18 PRKCB PRKCG | 1.42e-06 | 154 | 160 | 11 | MM15974 |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 9.53e-06 | 121 | 160 | 9 | M872 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.15e-05 | 68 | 160 | 7 | MM14968 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 1.69e-05 | 72 | 160 | 7 | M26954 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 2.00e-05 | 30 | 160 | 5 | M47724 | |
| Pathway | PID_NFAT_3PATHWAY | 2.88e-05 | 53 | 160 | 6 | M113 | |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA | 3.56e-05 | 55 | 160 | 6 | M41823 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 9.53e-05 | 41 | 160 | 5 | M39655 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 1.20e-04 | 43 | 160 | 5 | MM15679 | |
| Pathway | WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS | 1.34e-04 | 44 | 160 | 5 | M39673 | |
| Pathway | KEGG_MEDICUS_VARIANT_DELETED_DMD_TO_DYSTROPHIN_ASSOCIATED_PROTEIN_COMPLEX | 1.62e-04 | 10 | 160 | 3 | M47575 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 1.91e-04 | 74 | 160 | 6 | M16376 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 1.91e-04 | 74 | 160 | 6 | M39462 | |
| Pathway | PID_INSULIN_GLUCOSE_PATHWAY | 1.97e-04 | 26 | 160 | 4 | M247 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 1.97e-04 | 26 | 160 | 4 | M27053 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 2.04e-04 | 48 | 160 | 5 | M26964 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 2.04e-04 | 48 | 160 | 5 | MM14589 | |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND | 2.37e-04 | 77 | 160 | 6 | M41822 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 2.65e-04 | 28 | 160 | 4 | MM14711 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.71e-04 | 147 | 160 | 8 | MM15854 | |
| Pathway | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | 2.73e-04 | 51 | 160 | 5 | M7955 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | RPS6KA1 SPTA1 SPTBN1 SPTBN2 ACTB FRS2 ACTG1 NCK1 ITGA9 SEMA6D SCN8A PLXNB3 HSP90AB1 ARHGEF28 KALRN MSN ST8SIA2 | 2.89e-04 | 575 | 160 | 17 | M29853 |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 2.93e-04 | 12 | 160 | 3 | MM14482 | |
| Pathway | REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 2.93e-04 | 12 | 160 | 3 | M45022 | |
| Pathway | REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX | 2.93e-04 | 12 | 160 | 3 | MM15443 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 3.25e-04 | 151 | 160 | 8 | M39329 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 3.57e-04 | 83 | 160 | 6 | M8728 | |
| Pathway | REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX | 3.77e-04 | 13 | 160 | 3 | M27708 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 5.17e-04 | 203 | 160 | 9 | M5485 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 5.52e-04 | 90 | 160 | 6 | M835 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES | 5.68e-04 | 34 | 160 | 4 | MM15265 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 5.91e-04 | 15 | 160 | 3 | M26902 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 7.07e-04 | 257 | 160 | 10 | MM14755 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES | 7.09e-04 | 36 | 160 | 4 | M27549 | |
| Pathway | REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 7.21e-04 | 16 | 160 | 3 | M46428 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 7.30e-04 | 213 | 160 | 9 | M18306 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 7.88e-04 | 37 | 160 | 4 | MM15022 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | SPTA1 SPTBN1 SPTBN2 ACTB ACTG1 SNAP29 GRK3 AP1G2 RAB6A SFN RAB6B YWHAB YWHAE TFRC EXOC5 LNPEP PPP6R3 | 8.14e-04 | 630 | 160 | 17 | M11480 |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TO_ACTIN_SIGNALING_PATHWAY | 8.68e-04 | 17 | 160 | 3 | M47728 | |
| Pathway | PID_RAC1_REG_PATHWAY | 8.73e-04 | 38 | 160 | 4 | M241 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 8.73e-04 | 38 | 160 | 4 | M39549 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 8.73e-04 | 38 | 160 | 4 | MM14969 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 1.03e-03 | 18 | 160 | 3 | M840 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 1.03e-03 | 18 | 160 | 3 | MM15123 | |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 1.03e-03 | 18 | 160 | 3 | MM14510 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 1.11e-03 | 69 | 160 | 5 | MM15596 | |
| Pathway | PID_MTOR_4PATHWAY | 1.11e-03 | 69 | 160 | 5 | M121 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 1.17e-03 | 41 | 160 | 4 | MM15630 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.18e-03 | 142 | 160 | 7 | MM15576 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 1.18e-03 | 70 | 160 | 5 | M41806 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANXA2_S100A10_REGULATED_ACTIN_CYTOSKELETON | 1.25e-03 | 5 | 160 | 2 | M49034 | |
| Pathway | REACTOME_DISINHIBITION_OF_SNARE_FORMATION | 1.25e-03 | 5 | 160 | 2 | M26920 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 1.28e-03 | 42 | 160 | 4 | M41828 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 1.28e-03 | 42 | 160 | 4 | M41821 | |
| Pathway | KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION | 1.28e-03 | 42 | 160 | 4 | M16473 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 1.28e-03 | 42 | 160 | 4 | M27308 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 1.34e-03 | 72 | 160 | 5 | MM15381 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_TO_RAC_SIGNALING_PATHWAY | 1.42e-03 | 20 | 160 | 3 | M47737 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 1.52e-03 | 44 | 160 | 4 | MM15678 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.55e-03 | 149 | 160 | 7 | M41805 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_ACTIN_SIGNALING_PATHWAY | 1.64e-03 | 21 | 160 | 3 | M47722 | |
| Pathway | PID_P38_MK2_PATHWAY | 1.64e-03 | 21 | 160 | 3 | M199 | |
| Pathway | REACTOME_LIPID_PARTICLE_ORGANIZATION | 1.86e-03 | 6 | 160 | 2 | M27852 | |
| Pathway | REACTOME_LIPID_PARTICLE_ORGANIZATION | 1.86e-03 | 6 | 160 | 2 | MM15571 | |
| Pathway | PID_LKB1_PATHWAY | 1.95e-03 | 47 | 160 | 4 | M87 | |
| Pathway | WP_FOCAL_ADHESION | 1.96e-03 | 199 | 160 | 8 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.96e-03 | 199 | 160 | 8 | M7253 | |
| Pathway | KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION | 2.07e-03 | 116 | 160 | 6 | M2164 | |
| Pathway | REACTOME_RHOBTB2_GTPASE_CYCLE | 2.15e-03 | 23 | 160 | 3 | M41723 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 2.15e-03 | 23 | 160 | 3 | M47720 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 2.15e-03 | 23 | 160 | 3 | MM15216 | |
| Pathway | REACTOME_NEPHRIN_FAMILY_INTERACTIONS | 2.15e-03 | 23 | 160 | 3 | M913 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 2.28e-03 | 49 | 160 | 4 | M891 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 5.88e-17 | 15 | 217 | 9 | 16824795 | |
| Pubmed | Non-viral cellular substrates for human immunodeficiency virus type 1 protease. | 8.98e-17 | 10 | 217 | 8 | 1991513 | |
| Pubmed | FAM184B SPTA1 SPEF2 ACTBL2 SPTBN1 SPTBN2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 ACTN1 RYR2 POTEE DST MDN1 KRT77 SYCP1 CCDC89 TASOR SFN HSP90AB1 KRT19 POTEF PPFIA2 LMNB2 KRT79 YWHAB TFRC MSN NOP14 EIF4A2 DGKK CEP295 POTEJ POTEI ATP1A4 DOP1A | 1.00e-14 | 1442 | 217 | 39 | 35575683 | |
| Pubmed | Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. | 1.19e-14 | 9 | 217 | 7 | 8892894 | |
| Pubmed | 4.67e-14 | 17 | 217 | 8 | 8997639 | ||
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 5.51e-14 | 6 | 217 | 6 | 9971772 | |
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 5.51e-14 | 6 | 217 | 6 | 10074138 | |
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 5.51e-14 | 6 | 217 | 6 | 22989508 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 5.51e-14 | 6 | 217 | 6 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 5.51e-14 | 6 | 217 | 6 | 11709093 | |
| Pubmed | 5.51e-14 | 6 | 217 | 6 | 10049817 | ||
| Pubmed | 5.51e-14 | 6 | 217 | 6 | 12009869 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 5.51e-14 | 6 | 217 | 6 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 5.51e-14 | 6 | 217 | 6 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 5.51e-14 | 6 | 217 | 6 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 5.51e-14 | 6 | 217 | 6 | 8661406 | |
| Pubmed | 5.51e-14 | 6 | 217 | 6 | 23017337 | ||
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 5.51e-14 | 6 | 217 | 6 | 23875777 | |
| Pubmed | 5.51e-14 | 6 | 217 | 6 | 9841925 | ||
| Pubmed | 3.83e-13 | 7 | 217 | 6 | 22535526 | ||
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 3.83e-13 | 7 | 217 | 6 | 18443296 | |
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 3.83e-13 | 7 | 217 | 6 | 22640593 | |
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 3.83e-13 | 7 | 217 | 6 | 17504171 | |
| Pubmed | 3.83e-13 | 7 | 217 | 6 | 22465675 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | ACTBL2 SPTBN1 SPTBN2 ACTA1 ACTA2 ACTB ACTC1 POTEKP ACTN1 POTEE MYO3B HSP90AB1 KRT19 POTEF KRT79 YWHAB POTEJ POTEI | 3.87e-13 | 288 | 217 | 18 | 31501420 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SPTBN2 FRS2 NARS1 SYNC ITGAE DNAH14 POTEE AFAP1L2 DST MDN1 MYO3B SCN8A CPSF1 PLXNB3 DOP1B HSP90AB1 KRT19 PPFIA2 LRRC40 LMNB2 PPFIA3 GIMAP8 PRKCB CEP295 CFAP57 LONRF2 | 1.23e-12 | 736 | 217 | 26 | 29676528 |
| Pubmed | 1.53e-12 | 8 | 217 | 6 | 14694110 | ||
| Pubmed | 1.53e-12 | 8 | 217 | 6 | 20147394 | ||
| Pubmed | 1.53e-12 | 8 | 217 | 6 | 23260110 | ||
| Pubmed | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP EDC4 DUS3L POTEE KRT77 OSBPL1A RAB6A HSP90AB1 KRT4 KRT19 POTEF LRRC40 YTHDC2 CHD8 RFC5 KRT79 RAB6B YWHAB DNAH7 YWHAE NOP14 EIF4A2 POTEJ POTEI ATP1A4 | 1.67e-12 | 1153 | 217 | 32 | 29845934 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | ACTBL2 SPTBN1 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP POTEE RAB6A POTEF CHD8 RAB6B POTEJ POTEI ATP1A4 | 1.68e-12 | 271 | 217 | 17 | 32433965 |
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 4.55e-12 | 9 | 217 | 6 | 10556093 | |
| Pubmed | 4.55e-12 | 9 | 217 | 6 | 18775311 | ||
| Pubmed | 1.13e-11 | 10 | 217 | 6 | 1907279 | ||
| Pubmed | 1.13e-11 | 10 | 217 | 6 | 23575248 | ||
| Pubmed | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP STRIP2 POTEE DST CPSF1 HSP90AB1 CPA5 POTEF YWHAB YWHAE PPM1B ZNF665 TRAK2 CAPN15 | 1.36e-11 | 513 | 217 | 21 | 25798074 | |
| Pubmed | 2.48e-11 | 11 | 217 | 6 | 30962377 | ||
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 2.48e-11 | 11 | 217 | 6 | 23294842 | |
| Pubmed | Quantitative proteomic analysis of lentiviral vectors using 2-DE. | 2.48e-11 | 11 | 217 | 6 | 19639585 | |
| Pubmed | 4.93e-11 | 12 | 217 | 6 | 23071112 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | RPS6KA1 SPTA1 SPTBN1 ACTB NARS1 ACTN1 TOMM70 DST RAB6A SFN HSP90AB1 GRID2 LMNB2 PPFIA3 RAB6B YWHAB YWHAE RPH3A RGS18 PRKCB PRKCG ATP1A4 | 6.99e-11 | 621 | 217 | 22 | 22794259 |
| Pubmed | MYCBP2 SPTBN1 SPTBN2 ACTB EDC4 CYFIP1 DST MDN1 UBR5 DIAPH1 PLCL1 KCNT1 ANKS1A HSP90AB1 KALRN NSD1 CHD8 LMNB2 PPFIA3 YWHAB YWHAE RPH3A MSN EIF4A2 PDE4DIP PRKCB PRKCG | 8.56e-11 | 963 | 217 | 27 | 28671696 | |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | RPS6KA1 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP POTEE SFN HSP90AB1 POTEF YWHAE TFRC | 9.27e-11 | 256 | 217 | 15 | 24189400 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | ACTBL2 DHX38 ACTB ACTC1 ITGA9 STRIP2 SHKBP1 UBR5 DOP1B HSP90AB1 ACAD9 PPFIA2 PPFIA3 YWHAB YWHAE POLR3A TFRC PPP4R3B POTEI SNTB2 PPP6R3 | 1.04e-10 | 573 | 217 | 21 | 28330616 |
| Pubmed | 1.59e-10 | 14 | 217 | 6 | 21923909 | ||
| Pubmed | 1.59e-10 | 14 | 217 | 6 | 17411366 | ||
| Pubmed | 5.13e-10 | 96 | 217 | 10 | 23580065 | ||
| Pubmed | 6.43e-10 | 17 | 217 | 6 | 17360745 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | RNF130 SPTBN1 ACTB CARD10 EDC4 MDN1 DIAPH1 SNRNP40 CPSF1 HSP90AB1 DOCK2 LRRC40 YTHDC2 CHD8 RFC5 YWHAE EXOC5 IPO9 EIF4A2 SMARCA2 | 9.03e-10 | 582 | 217 | 20 | 20467437 |
| Pubmed | 9.60e-10 | 18 | 217 | 6 | 24840128 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 HIPK1 DHX38 ANKRD49 ACTC1 DAXX POTEE CYFIP1 UBR5 BANP DIAPH1 FAM135A RAB6A KRT19 CIP2A PPP4R3B MTR POTEJ POTEI PPP6R3 | 1.08e-09 | 588 | 217 | 20 | 38580884 |
| Pubmed | 1.11e-09 | 9 | 217 | 5 | 16364570 | ||
| Pubmed | ACTBL2 SPTBN1 ACTB ACTC1 ACTG1 ACTN1 POTEE DST SNRNP40 CPSF1 KRT19 LMNB2 RFC5 YWHAB YWHAE PPM1B TFRC MSN EIF4A2 POTEJ SNTB2 | 1.33e-09 | 660 | 217 | 21 | 32780723 | |
| Pubmed | SPTA1 ACTBL2 SPTBN1 SPTBN2 ACTA1 ACTB NARS1 ACTG1 ACTN1 EDC4 ITPKA ITPKB TOMM70 CYFIP1 DST PLCL1 HSP90AB1 KALRN KRT19 PPFIA2 RBP3 YTHDC2 PPFIA3 ATP9A KRT79 YWHAB YWHAE RPH3A PDE4DIP PRKCB PRKCG | 1.72e-09 | 1431 | 217 | 31 | 37142655 | |
| Pubmed | USP34 MYCBP2 HIPK1 SPTBN1 SPTBN2 ACTB ANKRD49 NARS1 NCK1 SYNC ACTN1 DST HPF1 VPS35L OSBPL1A RAB6A PLXNB3 DOP1B HSP90AB1 PRKD2 KALRN YWHAB YWHAE RPH3A PPP4R3B PPT1 EIF4A2 PDE4DIP NECAB3 | 2.45e-09 | 1285 | 217 | 29 | 35914814 | |
| Pubmed | TPO ACTBL2 SPTBN2 ACTB ACTC1 POTEE TTBK2 POTEF TFRC POTEJ POTEI | 2.81e-09 | 149 | 217 | 11 | 22664934 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | CALCOCO2 SPTBN1 ACTA2 ACTB TATDN2 ACTC1 ACTG1 ACTN1 KRT77 SFN HSP90AB1 KRT4 KRT79 YWHAB YWHAE TFRC EXOC5 IPO9 EIF4A2 | 3.35e-09 | 564 | 217 | 19 | 21565611 |
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 3.78e-09 | 22 | 217 | 6 | 16526095 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | SPTBN1 SPTBN2 ACTA2 ACTB NARS1 ACTC1 ACTG1 ACTN1 CYFIP1 MDN1 SNRNP40 SFN HSP90AB1 RFC5 YWHAB YWHAE POLR3A MSN PPP4R3B IPO9 EIF4A2 SMARCA2 DOP1A | 4.28e-09 | 847 | 217 | 23 | 35235311 |
| Pubmed | Essential and supporting host cell factors for HIV-1 budding. | 5.09e-09 | 23 | 217 | 6 | 22004035 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MYCBP2 SPTBN1 EDC4 MAST2 ITPKB SHKBP1 DST MDN1 KRT77 CCSER2 DOCK6 SFN DOP1B ANKS1A ARHGEF28 KRT19 POTEF YWHAB DNAH7 YWHAE IPO9 PRKCG DOP1A | 5.81e-09 | 861 | 217 | 23 | 36931259 |
| Pubmed | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 HSP90AB1 PPFIA2 CHD8 YWHAB TFRC EIF4A2 | 6.24e-09 | 247 | 217 | 13 | 30713523 | |
| Pubmed | MYCBP2 ACTB ACTG1 POTEKP EDC4 KRT77 DIAPH1 CPSF1 POTEF KRT79 TFRC POTEJ | 6.27e-09 | 202 | 217 | 12 | 24639526 | |
| Pubmed | USP34 MYCBP2 SPTBN1 SPTBN2 DHX38 NARS1 ACTN1 EDC4 DST MDN1 UBR5 CPSF1 NSD1 YTHDC2 CHD8 LMNB2 MSN NOP14 SMARCA2 PPP6R3 | 6.36e-09 | 653 | 217 | 20 | 22586326 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYCBP2 SPTBN1 SNX17 DHX38 ACTB NARS1 ACTN1 DUS3L CYFIP1 DST MDN1 UBR5 DIAPH1 SNRNP40 CPSF1 AP1G2 HSP90AB1 LRRC40 CHD8 LMNB2 RFC5 YWHAB YWHAE POLR3A TFRC MSN IPO9 NOP14 SMARCA2 | 7.69e-09 | 1353 | 217 | 29 | 29467282 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYCBP2 SPTA1 ACTBL2 SPTBN1 ACTB ACTN1 EDC4 TOMM70 DST MDN1 KRT77 SCN8A DIAPH1 RAB6A SFN HSP90AB1 DOCK2 CHD8 KRT79 YWHAB YWHAE TFRC | 8.84e-09 | 807 | 217 | 22 | 30575818 |
| Pubmed | SPTBN1 ACTB ACTC1 POTEKP ACTN1 PDCD4 DST MDN1 UBR5 DIAPH1 SFN HSP90AB1 POTEF YWHAB YWHAE MSN IPO9 PPP6R3 | 9.80e-09 | 538 | 217 | 18 | 28524877 | |
| Pubmed | 1.14e-08 | 26 | 217 | 6 | 24742657 | ||
| Pubmed | MYCBP2 ACTBL2 SPTBN1 SNX17 SPTBN2 DHX38 ACTA1 ACTB ACTG1 SHKBP1 TOMM70 CPSF1 HSP90AB1 CIP2A FBXL14 PPFIA3 YWHAB YWHAE PPM1B PPP4R3B IPO9 NOP14 LNPEP SNTB2 PPP6R3 | 1.18e-08 | 1049 | 217 | 25 | 27880917 | |
| Pubmed | SPTA1 SPTBN1 ACTA1 ACTB ACTN1 EDC4 KRT77 SFN HSP90AB1 KRT4 KRT19 KRT79 YWHAB | 1.51e-08 | 266 | 217 | 13 | 19380743 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYCBP2 DHX38 BARD1 PDCD4 STRIP2 SHKBP1 UBR5 KRT77 SNRNP40 PRKD2 KRT4 KRT19 ACAD9 YTHDC2 KRT79 YWHAB YWHAE POLR3A IPO9 EIF4A2 SMARCA2 LONRF2 SNTB2 PPP6R3 | 2.27e-08 | 1005 | 217 | 24 | 19615732 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ACTBL2 SPTBN1 SPTBN2 DHX38 ACTB NARS1 ACTC1 ACTN1 EDC4 PDCD4 CYFIP1 DST KRT77 SNRNP40 CPSF1 SFN HSP90AB1 KRT4 YTHDC2 LMNB2 RFC5 KRT79 YWHAB YWHAE MSN NOP14 SNTB2 | 2.54e-08 | 1257 | 217 | 27 | 36526897 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | SPTBN1 SPTBN2 ACTN1 ITPKA CYFIP1 GRK3 UBR5 PLCL1 KALRN PPFIA2 YWHAE PRKCB PRKCG | 2.88e-08 | 281 | 217 | 13 | 28706196 |
| Pubmed | SPTA1 SPTBN1 SPTBN2 ACTA1 ACTG1 ITPKA PPFIA2 PPFIA3 YWHAB YWHAE | 3.28e-08 | 147 | 217 | 10 | 16959763 | |
| Pubmed | 3.28e-08 | 147 | 217 | 10 | 26465331 | ||
| Pubmed | ACTB ACTN1 PDCD4 MDN1 UBR5 HSP90AB1 CIP2A LMNB2 RFC5 YWHAB YWHAE CIDEC EIF4A2 | 3.84e-08 | 288 | 217 | 13 | 23383273 | |
| Pubmed | Proteomic analysis reveals novel binding partners of MIP-T3 in human cells. | 6.40e-08 | 34 | 217 | 6 | 20391533 | |
| Pubmed | PDZK1 ACTBL2 DHX38 ACTB DAXX ACTN1 EDC4 SHKBP1 POTEE TOMM70 CYFIP1 DST MDN1 ARHGEF9 TASOR ACAD9 NSD1 YTHDC2 CHD8 ATP9A RFC5 RAB6B YWHAE DNTTIP1 NOP14 LNPEP SMARCA2 SNTB2 PPP6R3 | 6.84e-08 | 1497 | 217 | 29 | 31527615 | |
| Pubmed | SPTBN1 SPTBN2 CYFIP1 UBR5 DIAPH1 PLCL1 ANKS1A KALRN YWHAB YWHAE PRKCB PRKCG | 6.95e-08 | 251 | 217 | 12 | 27507650 | |
| Pubmed | ACTBL2 SPTBN1 ACTB ACTG1 ACTG2 ACTN1 EDC4 CYFIP1 KRT77 DIAPH1 SFN HSP90AB1 KRT19 YWHAB YWHAE EIF4A2 | 8.78e-08 | 488 | 217 | 16 | 31324722 | |
| Pubmed | BARD1 RYR2 ITPKB TTBK2 CYFIP1 MDN1 RAB6A PPFIA3 DNAH7 ABCC6 IPO9 DNAH12 PPT1 ZNF665 SMARCA2 CEP295 POTEJ SNTB2 | 1.28e-07 | 638 | 217 | 18 | 31182584 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYCBP2 ACTBL2 SPTBN2 ACTA1 ACTC1 ACTG1 ACTN1 EDC4 FBXW8 DST MDN1 UBR5 KRT77 SNRNP40 CPSF1 HSP90AB1 LRRC40 YTHDC2 LMNB2 RFC5 YWHAB YWHAE TFRC | 1.35e-07 | 1024 | 217 | 23 | 24711643 |
| Pubmed | ACTBL2 SPTBN1 ACTA1 ACTB ACTC1 SNAP29 CYFIP1 DST DIAPH1 SNRNP40 CPSF1 POTEF YWHAB YWHAE POTEJ POTEI | 1.43e-07 | 506 | 217 | 16 | 30890647 | |
| Pubmed | Actin and myosin genes are transcriptionally regulated during mouse skeletal muscle development. | 2.40e-07 | 3 | 217 | 3 | 1728592 | |
| Pubmed | Restricted morphological and behavioral abnormalities following ablation of β-actin in the brain. | 2.40e-07 | 3 | 217 | 3 | 22403730 | |
| Pubmed | 2.40e-07 | 3 | 217 | 3 | 3842206 | ||
| Pubmed | 2.40e-07 | 3 | 217 | 3 | 6641707 | ||
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 2.40e-07 | 3 | 217 | 3 | 17101985 | |
| Pubmed | Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization. | 2.40e-07 | 3 | 217 | 3 | 7780165 | |
| Pubmed | 2.40e-07 | 3 | 217 | 3 | 12747803 | ||
| Pubmed | 2.40e-07 | 3 | 217 | 3 | 6865942 | ||
| Pubmed | 2.40e-07 | 3 | 217 | 3 | 3084797 | ||
| Pubmed | ZNF862 HIPK1 CARD10 DST BANP OSBPL5 KALRN YTHDC2 DNAH7 PDE4DIP CEP295 | 2.80e-07 | 233 | 217 | 11 | 37704626 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | ACTA1 ACTA2 ACTB NARS1 ACTC1 ACTG1 ACTG2 POTEKP ACTN1 POTEE CYFIP1 ST3GAL6 KRT77 SFN DOP1B HSP90AB1 POTEF KRT79 YWHAE MSN PPT1 POTEJ POTEI | 2.93e-07 | 1070 | 217 | 23 | 23533145 |
| Pubmed | 3.14e-07 | 143 | 217 | 9 | 22516433 | ||
| Pubmed | CALCOCO2 GLT8D1 MYCBP2 DHX38 ACTB ACTC1 ACTG1 EDC4 ITGB7 TOMM70 MDN1 UBR5 OSBPL5 HSP90AB1 DOCK2 LRRC40 YWHAB YWHAE BTN3A2 POLR3A IPO9 NOP14 PPT1 LNPEP | 3.58e-07 | 1168 | 217 | 24 | 19946888 | |
| Pubmed | USP34 ACTBL2 SPTBN1 SPTBN2 ACTA2 NARS1 CARD10 EDC4 PDCD4 SNAP29 TOMM70 DST MDN1 UBR5 VPS35L SNRNP40 ACAD9 CIP2A YTHDC2 RFC5 YWHAB YWHAE POLR3A TFRC EXOC5 IPO9 PPP6R3 | 3.83e-07 | 1440 | 217 | 27 | 30833792 | |
| Pubmed | ACTBL2 ACTA1 ACTA2 NARS1 ACTC1 ACTG1 ACTG2 ACTN1 TTBK2 TOMM70 DST SYCP1 SFN HSP90AB1 DOCK2 KRT19 YWHAB YWHAE MSN EIF4A2 | 4.05e-07 | 844 | 217 | 20 | 25963833 | |
| Pubmed | 4.70e-07 | 11 | 217 | 4 | 22207710 | ||
| Pubmed | 4.98e-07 | 151 | 217 | 9 | 17043677 | ||
| Interaction | ACTG2 interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEE POTEF POTEJ POTEI | 3.06e-12 | 49 | 214 | 11 | int:ACTG2 |
| Interaction | CAP2 interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 HSP90AB1 POTEF YWHAE POTEJ POTEI | 9.64e-11 | 66 | 214 | 11 | int:CAP2 |
| Interaction | ERRFI1 interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP POTEE SFN POTEF YWHAB YWHAE | 1.14e-10 | 107 | 214 | 13 | int:ERRFI1 |
| Interaction | POTEJ interactions | 1.58e-10 | 52 | 214 | 10 | int:POTEJ | |
| Interaction | SPTAN1 interactions | CALCOCO2 MYCBP2 SPTBN1 SPTBN2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTN1 EPB41L4A CYFIP1 DST UBR5 SFN HSP90AB1 KALRN YWHAB YWHAE PPM1B TFRC MSN PPT1 PRKCB | 6.66e-10 | 496 | 214 | 24 | int:SPTAN1 |
| Interaction | ACTA1 interactions | SPTA1 ACTBL2 SPTBN2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 ITPKA POTEE CYFIP1 DST SFN POTEF PPM1B PRKCB POTEJ POTEI | 1.79e-08 | 371 | 214 | 19 | int:ACTA1 |
| Interaction | POTEE interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEE CPA5 ARHGEF25 POTEJ POTEI | 2.04e-08 | 134 | 214 | 12 | int:POTEE |
| Interaction | PFN3 interactions | 3.11e-08 | 10 | 214 | 5 | int:PFN3 | |
| Interaction | PLEC interactions | CALCOCO2 SPTA1 SPEF2 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 DST DNAH5 SFN KRT19 ARHGEF25 MSN THRB PPT1 PDE4DIP MTR | 3.69e-08 | 430 | 214 | 20 | int:PLEC |
| Interaction | ACTA2 interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP POTEE ALOX12 SFN POTEF YWHAB YWHAE THRB PPT1 POTEJ POTEI | 5.02e-08 | 355 | 214 | 18 | int:ACTA2 |
| Interaction | WASH8P interactions | 5.65e-08 | 11 | 214 | 5 | int:WASH8P | |
| Interaction | NEK4 interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP STRIP2 POTEE DST CPSF1 SFN HSP90AB1 CPA5 POTEF YWHAB YWHAE PPM1B ZNF665 MTR TRAK2 CAPN15 | 6.70e-08 | 582 | 214 | 23 | int:NEK4 |
| Interaction | ABRA interactions | 8.87e-08 | 36 | 214 | 7 | int:ABRA | |
| Interaction | NCKAP1 interactions | SPTBN1 SPTBN2 ACTA1 ACTB ACTC1 ACTG1 CDH23 NCK1 PDCD4 CYFIP1 YWHAB YWHAE PPM1B TMEM132D | 9.25e-08 | 218 | 214 | 14 | int:NCKAP1 |
| Interaction | HEXIM1 interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP EDC4 POTEE KRT77 OSBPL1A SNRNP40 RAB6A HSP90AB1 KRT4 KRT19 POTEF YTHDC2 RFC5 KRT79 RAB6B DNAH7 YWHAE NOP14 EIF4A2 POTEJ POTEI ATP1A4 | 1.35e-07 | 913 | 214 | 29 | int:HEXIM1 |
| Interaction | SCIN interactions | 1.72e-07 | 58 | 214 | 8 | int:SCIN | |
| Interaction | POTEI interactions | 1.77e-07 | 105 | 214 | 10 | int:POTEI | |
| Interaction | RNF123 interactions | SPTBN2 FRS2 NARS1 ACTG1 SYNC ITGAE DNAH14 POTEE AFAP1L2 DST MDN1 MYO3B SCN8A CPSF1 PLXNB3 DOP1B HSP90AB1 KRT19 PPFIA2 LRRC40 LMNB2 PPFIA3 GIMAP8 PRKCB CEP295 CFAP57 LONRF2 | 2.07e-07 | 824 | 214 | 27 | int:RNF123 |
| Interaction | GC interactions | 2.93e-07 | 62 | 214 | 8 | int:GC | |
| Interaction | SPIRE1 interactions | 3.28e-07 | 27 | 214 | 6 | int:SPIRE1 | |
| Interaction | NAA80 interactions | 3.55e-07 | 15 | 214 | 5 | int:NAA80 | |
| Interaction | DNASE1 interactions | 4.22e-07 | 7 | 214 | 4 | int:DNASE1 | |
| Interaction | PHACTR2 interactions | 5.18e-07 | 29 | 214 | 6 | int:PHACTR2 | |
| Interaction | DBN1 interactions | CALCOCO2 MYCBP2 ACTBL2 SPTBN1 ACTA2 ACTB ACTC1 ACTG1 CARD10 POTEKP ACTN1 ITPKA CYFIP1 DST UBR5 HSP90AB1 YWHAE PPT1 | 5.45e-07 | 417 | 214 | 18 | int:DBN1 |
| Interaction | BRK1 interactions | ACTBL2 ACTA1 ACTG1 NCK1 CYFIP1 BANP CCSER2 POC1A PPFIA2 PPFIA3 | 8.41e-07 | 124 | 214 | 10 | int:BRK1 |
| Interaction | CALD1 interactions | ACTBL2 SPTBN1 SPTBN2 ACTA2 ACTB ACTC1 ACTG1 ACTN1 POTEE DST PRKD2 YWHAE TFRC MSN | 9.92e-07 | 265 | 214 | 14 | int:CALD1 |
| Interaction | TFCP2 interactions | ACTBL2 SPTBN1 SPTBN2 ACTA1 ACTA2 ACTB ACTC1 POTEKP ACTN1 POTEE MYO3B HSP90AB1 KRT19 POTEF KRT79 YWHAB POTEJ POTEI | 1.04e-06 | 436 | 214 | 18 | int:TFCP2 |
| Interaction | POTEF interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP STRIP2 POC1A POTEF YWHAB YWHAE | 1.04e-06 | 228 | 214 | 13 | int:POTEF |
| Interaction | PDCL3 interactions | 1.20e-06 | 100 | 214 | 9 | int:PDCL3 | |
| Interaction | PLEKHG3 interactions | 1.20e-06 | 100 | 214 | 9 | int:PLEKHG3 | |
| Interaction | LRRC20 interactions | 1.33e-06 | 19 | 214 | 5 | int:LRRC20 | |
| Interaction | ERBB3 interactions | MYCBP2 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 NCK1 POTEKP POTEE HSP90AB1 SLC31A1 BEND5 POTEF PPM1B | 1.36e-06 | 355 | 214 | 16 | int:ERBB3 |
| Interaction | CDC5L interactions | RNF130 SPTBN1 DHX38 ACTB ACTC1 CARD10 EDC4 DST MDN1 UBR5 DIAPH1 SNRNP40 HSP90AB1 KALRN PPFIA2 LRRC40 CHD8 RFC5 YWHAE EXOC5 IPO9 NOP14 EIF4A2 PDE4DIP SMARCA2 PPP6R3 | 1.44e-06 | 855 | 214 | 26 | int:CDC5L |
| Interaction | ACTC1 interactions | ACTBL2 SPTBN1 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 SNAP29 POTEE FBXW8 CYFIP1 DST DIAPH1 SNRNP40 CPSF1 POTEF YWHAB YWHAE SMARCA2 POTEJ POTEI DOP1A | 1.46e-06 | 694 | 214 | 23 | int:ACTC1 |
| Interaction | DAB2IP interactions | SNX17 STRIP2 TOMM70 ANKS1A KALRN SLC31A1 YWHAB YWHAE SMARCA2 | 1.54e-06 | 103 | 214 | 9 | int:DAB2IP |
| Interaction | HSPB2 interactions | AUH SPTBN1 ACTA1 ACTB NARS1 ACTC1 ACTG1 DAXX ACTN1 RYR2 CHD8 EIF4A2 | 1.60e-06 | 200 | 214 | 12 | int:HSPB2 |
| Interaction | SPIRE2 interactions | 2.28e-06 | 21 | 214 | 5 | int:SPIRE2 | |
| Interaction | HOMER1 interactions | 2.55e-06 | 140 | 214 | 10 | int:HOMER1 | |
| Interaction | SPTBN1 interactions | CALCOCO2 MYCBP2 SPTBN1 SPTBN2 ACTB ACTC1 ACTG1 EPB41L4A CYFIP1 UBR5 SFN KALRN LMNB2 YWHAB PPM1B TFRC PPT1 | 2.81e-06 | 421 | 214 | 17 | int:SPTBN1 |
| Interaction | HTT interactions | CALCOCO2 RPS6KA1 SPTA1 ACTBL2 SPTBN1 ACTA1 ACTB NARS1 ACTG1 ACTN1 TOMM70 DST RAB6A SFN HSP90AB1 GRID2 LMNB2 PPFIA3 RAB6B YWHAB YWHAE RPH3A RGS18 IPO9 PRKCB PRKCG ATP1A4 | 3.12e-06 | 949 | 214 | 27 | int:HTT |
| Interaction | ACTG1 interactions | ACTBL2 SPTBN1 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEE CYFIP1 DST SFN HSP90AB1 POTEF YWHAB IPO9 SMARCA2 POTEJ POTEI | 3.12e-06 | 520 | 214 | 19 | int:ACTG1 |
| Interaction | TNIK interactions | CALCOCO2 MYCBP2 SPTBN1 SPTBN2 ACTG1 NCK1 EDC4 CYFIP1 DST SFN KALRN CHD8 LMNB2 PDE4DIP PRKCB PRKCG | 3.38e-06 | 381 | 214 | 16 | int:TNIK |
| Interaction | ACTBL2 interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEE UBR5 POTEF THRB SMARCA2 POTEJ POTEI | 3.63e-06 | 296 | 214 | 14 | int:ACTBL2 |
| Interaction | ACTB interactions | CALCOCO2 ACTBL2 SPTBN1 SPTBN2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP PDCD4 ITPKA POTEE CYFIP1 DST DIAPH1 DNAH5 HSP90AB1 POTEF YWHAB YWHAE MSN IPO9 THRB PPT1 SMARCA2 POTEJ POTEI | 4.28e-06 | 1083 | 214 | 29 | int:ACTB |
| Interaction | ABI1 interactions | SPTA1 DHX38 ACTB ACTC1 ACTG1 CDH23 NCK1 PDCD4 CYFIP1 DST C22orf15 YWHAE | 4.96e-06 | 223 | 214 | 12 | int:ABI1 |
| Interaction | ARHGEF28 interactions | 5.10e-06 | 42 | 214 | 6 | int:ARHGEF28 | |
| Interaction | YAP1 interactions | ACTBL2 SPTBN1 SPTBN2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 NCK1 POTEKP ACTN1 EDC4 LAPTM5 POTEE CYFIP1 MYO3B SFN HSP90AB1 KRT19 ACAD9 POTEF NSD1 CHD8 KRT79 YWHAB YWHAE SMARCA2 POTEJ POTEI | 5.29e-06 | 1095 | 214 | 29 | int:YAP1 |
| Interaction | SYNGAP1 interactions | MYCBP2 PDE6B SPTBN1 SPTBN2 STRIP2 ITPKA CYFIP1 GRK3 UBR5 PLCL1 ANKS1A KALRN YWHAE PRKCG | 5.53e-06 | 307 | 214 | 14 | int:SYNGAP1 |
| Interaction | C6orf132 interactions | 5.76e-06 | 25 | 214 | 5 | int:C6orf132 | |
| Interaction | YWHAH interactions | MYCBP2 RPS6KA1 SPTBN1 DHX38 EDC4 MAST2 PDCD4 SHKBP1 CYFIP1 DST KRT77 OSBPL5 CCSER2 DOCK6 SUCO SFN DOP1B ANKS1A HSP90AB1 PRKD2 ARHGEF28 KRT19 POTEF YWHAB DNAH7 YWHAE RPH3A IPO9 DOP1A | 5.98e-06 | 1102 | 214 | 29 | int:YWHAH |
| Interaction | PLK4 interactions | MYCBP2 ACTBL2 ACTA1 CCSER2 SFN ATP9A YWHAB YWHAE PPM1B POTEI | 6.00e-06 | 154 | 214 | 10 | int:PLK4 |
| Interaction | SORBS1 interactions | 6.71e-06 | 123 | 214 | 9 | int:SORBS1 | |
| Interaction | DMTN interactions | 6.74e-06 | 44 | 214 | 6 | int:DMTN | |
| Interaction | KLC4 interactions | 7.65e-06 | 125 | 214 | 9 | int:KLC4 | |
| Interaction | TRAF3IP1 interactions | 8.44e-06 | 96 | 214 | 8 | int:TRAF3IP1 | |
| Interaction | YWHAG interactions | CALCOCO2 MYCBP2 RPS6KA1 SPTBN1 ACTC1 EDC4 MAST2 PDCD4 ITPKB SHKBP1 CYFIP1 DST MDN1 KRT77 CCSER2 SUCO SFN ANKS1A HSP90AB1 ARHGEF28 KRT19 POTEF YWHAB DNAH7 YWHAE IPO9 PPT1 PRKCB PRKCG DOP1A PPP6R3 | 8.83e-06 | 1248 | 214 | 31 | int:YWHAG |
| Interaction | RNASE3 interactions | 1.14e-05 | 14 | 214 | 4 | int:RNASE3 | |
| Interaction | NUPR1 interactions | ACTBL2 SPTBN1 ACTB ACTC1 ACTG1 ACTN1 POTEE DST SNRNP40 CPSF1 KRT19 LMNB2 RFC5 YWHAB YWHAE PPM1B TFRC MSN EIF4A2 POTEJ SNTB2 | 1.34e-05 | 683 | 214 | 21 | int:NUPR1 |
| Interaction | MACF1 interactions | MYCBP2 DHX38 ACTA1 ACTB DAXX EPB41L4A SNAP29 CYFIP1 SFN KALRN YWHAB YWHAE | 1.39e-05 | 247 | 214 | 12 | int:MACF1 |
| Interaction | FBXO40 interactions | 1.54e-05 | 15 | 214 | 4 | int:FBXO40 | |
| Interaction | KLC2 interactions | ACTG1 SFN LMNB2 NAALADL2 YWHAB YWHAE PPP4R3B IPO9 PPT1 TRAK2 | 1.58e-05 | 172 | 214 | 10 | int:KLC2 |
| Interaction | SPTBN2 interactions | CALCOCO2 MYCBP2 SPTA1 SPTBN1 SPTBN2 ACTA1 ACTB CYFIP1 KALRN TFRC | 1.58e-05 | 172 | 214 | 10 | int:SPTBN2 |
| Interaction | COBLL1 interactions | 1.62e-05 | 76 | 214 | 7 | int:COBLL1 | |
| Interaction | PRKCE interactions | ACTA1 ACTB ACTC1 CYFIP1 SFN HSP90AB1 YWHAB YWHAE PRKCB PRKCG | 1.67e-05 | 173 | 214 | 10 | int:PRKCE |
| Interaction | ADARB1 interactions | CENPN ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 POTEKP RAB6A POTEF YTHDC2 CHD8 RAB6B POTEJ POTEI ATP1A4 | 1.99e-05 | 489 | 214 | 17 | int:ADARB1 |
| Interaction | WIPF3 interactions | 2.04e-05 | 16 | 214 | 4 | int:WIPF3 | |
| Interaction | SSH1 interactions | 2.09e-05 | 79 | 214 | 7 | int:SSH1 | |
| Interaction | CYFIP1 interactions | SPTBN1 SPTBN2 ACTA1 ACTB ACTC1 ACTG1 CDH23 NCK1 CYFIP1 YWHAB TMEM132D PRKCB PRKCG | 2.29e-05 | 303 | 214 | 13 | int:CYFIP1 |
| Interaction | LGR4 interactions | MYCBP2 ACTB ACTG1 POTEKP EDC4 KRT77 CPSF1 SLC31A1 POTEF KRT79 TFRC POTEJ | 2.50e-05 | 262 | 214 | 12 | int:LGR4 |
| Interaction | YWHAZ interactions | MYCBP2 SPTA1 SPTBN1 SPTBN2 ACTA1 BARD1 ACTC1 ACTG1 POTEKP MAST2 ITPKA CYFIP1 DST KRT77 CCSER2 SNRNP40 SUCO SFN ANKS1A HSP90AB1 PRKD2 ARHGEF28 POTEF PPFIA2 PPFIA3 YWHAB YWHAE MSN EXOC5 IPO9 PPT1 | 2.60e-05 | 1319 | 214 | 31 | int:YWHAZ |
| Interaction | REG3A interactions | 2.64e-05 | 17 | 214 | 4 | int:REG3A | |
| Interaction | TMSB10 interactions | 2.79e-05 | 56 | 214 | 6 | int:TMSB10 | |
| Interaction | DSCR9 interactions | 2.82e-05 | 147 | 214 | 9 | int:DSCR9 | |
| Interaction | FAM53B interactions | 3.37e-05 | 18 | 214 | 4 | int:FAM53B | |
| Interaction | ARHGEF5 interactions | 3.38e-05 | 85 | 214 | 7 | int:ARHGEF5 | |
| Interaction | MAST2 interactions | 3.41e-05 | 58 | 214 | 6 | int:MAST2 | |
| Interaction | WASL interactions | 3.59e-05 | 117 | 214 | 8 | int:WASL | |
| Interaction | GSK3A interactions | CALCOCO2 EDC4 DST MDN1 UBR5 SFN ANKS1A HSP90AB1 CIP2A YTHDC2 YWHAB YWHAE PRKCB PRKCG TRAK2 PPP6R3 | 3.87e-05 | 464 | 214 | 16 | int:GSK3A |
| Interaction | TSC1 interactions | CALCOCO2 RPS6KA1 ACTA1 ACTN1 CYFIP1 HSP90AB1 BEND5 PPFIA2 YWHAB YWHAE MSN EIF4A2 PRKCB PRKCG | 3.93e-05 | 366 | 214 | 14 | int:TSC1 |
| Interaction | SVIL interactions | MYCBP2 SPTBN1 ACTB ACTN1 SYCP1 SFN HSP90AB1 LMNB2 YWHAB YWHAE TMEM132D | 4.15e-05 | 233 | 214 | 11 | int:SVIL |
| Interaction | PRKCG interactions | 4.57e-05 | 121 | 214 | 8 | int:PRKCG | |
| Interaction | MAP7D3 interactions | 5.13e-05 | 123 | 214 | 8 | int:MAP7D3 | |
| Interaction | SFN interactions | MYCBP2 SPTBN1 ACTA1 ACTA2 ACTG1 ACTN1 EDC4 MAST2 DST KRT77 BANP CCSER2 SFN ANKS1A ARHGEF28 KRT19 YWHAB YWHAE IPO9 DOP1A | 5.17e-05 | 692 | 214 | 20 | int:SFN |
| Interaction | PRR5 interactions | 5.53e-05 | 39 | 214 | 5 | int:PRR5 | |
| Interaction | DTNA interactions | 5.76e-05 | 125 | 214 | 8 | int:DTNA | |
| Interaction | DISC1 interactions | ACTBL2 SPTBN1 DHX38 ACTC1 ACTG1 ACTN1 KATNAL1 DST UBR5 KALRN PPFIA3 YWHAE IPO9 PDE4DIP PPP6R3 | 5.80e-05 | 429 | 214 | 15 | int:DISC1 |
| Interaction | AGR2 interactions | MYCBP2 SPTA1 ACTBL2 SPTBN1 ACTB ACTN1 EDC4 TOMM70 DST MDN1 KRT77 SCN8A DIAPH1 RAB6A SFN HSP90AB1 DOCK2 RBP5 NSD1 CHD8 KRT79 YWHAB YWHAE TFRC | 5.90e-05 | 934 | 214 | 24 | int:AGR2 |
| Interaction | DST interactions | MYCBP2 ACTA1 ACTB ACTC1 ACTG1 POTEKP EPB41L4A DST SFN PRKD2 YWHAB YWHAE | 6.06e-05 | 287 | 214 | 12 | int:DST |
| Interaction | KCNK15 interactions | 6.36e-05 | 8 | 214 | 3 | int:KCNK15 | |
| Interaction | WASH3P interactions | 7.07e-05 | 41 | 214 | 5 | int:WASH3P | |
| Interaction | TEDC2 interactions | TDRD9 SPTBN1 ACTB ACTG1 AFAP1L2 DST KRT77 HSP90AB1 CHD8 TFRC | 7.37e-05 | 206 | 214 | 10 | int:TEDC2 |
| Interaction | CAP1 interactions | ACTBL2 ACTA1 ACTA2 ACTB BARD1 ACTC1 ACTG1 HSP90AB1 ISYNA1 POTEI | 7.67e-05 | 207 | 214 | 10 | int:CAP1 |
| Interaction | TPM3 interactions | CENPN ACTA1 ACTB ACTG1 ACTN1 MAST2 RYR2 UBR5 KCNE1 HSP90AB1 PLCH2 EIF4A2 SMARCA2 PPP6R3 | 7.77e-05 | 390 | 214 | 14 | int:TPM3 |
| Interaction | YWHAB interactions | MYCBP2 RPS6KA1 SPTBN1 ACTA2 ACTB ACTC1 ACTG1 MAST2 ITPKB SHKBP1 CYFIP1 DST KRT77 CCSER2 SUCO SFN ANKS1A HSP90AB1 ARHGEF28 POTEF YWHAB YWHAE IPO9 PPT1 PRKCG | 7.96e-05 | 1014 | 214 | 25 | int:YWHAB |
| Interaction | GAN interactions | SPTA1 ACTBL2 ACTG1 SYNC MAST2 DST SFN HSP90AB1 POTEF CIP2A LMNB2 | 8.70e-05 | 253 | 214 | 11 | int:GAN |
| Interaction | SSH2 interactions | 8.93e-05 | 43 | 214 | 5 | int:SSH2 | |
| Interaction | PPFIBP2 interactions | 8.93e-05 | 43 | 214 | 5 | int:PPFIBP2 | |
| Interaction | GSN interactions | MYCBP2 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 POTEF PPM1B POTEI | 9.35e-05 | 212 | 214 | 10 | int:GSN |
| Interaction | CFTR interactions | PDZK1 ACTBL2 SPTBN1 ACTB ANKRD49 ACTG1 ACTG2 ACTN1 KATNAL1 EDC4 ITGB7 RYR2 TTBK2 CYFIP1 MDN1 UBR5 KRT77 ARHGEF9 DIAPH1 SFN HSP90AB1 KRT19 BEND5 CIP2A LMNB2 RFC5 YWHAB YWHAE MSN IPO9 EIF4A2 PPP6R3 | 9.41e-05 | 1480 | 214 | 32 | int:CFTR |
| Interaction | KCNK9 interactions | 9.46e-05 | 9 | 214 | 3 | int:KCNK9 | |
| Cytoband | 2q21.1 | 3.43e-07 | 58 | 217 | 6 | 2q21.1 | |
| Cytoband | 12q13.13 | 2.95e-04 | 67 | 217 | 4 | 12q13.13 | |
| GeneFamily | Actins | 2.61e-13 | 6 | 147 | 6 | 929 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 4.05e-08 | 13 | 147 | 5 | 685 | |
| GeneFamily | Dyneins, axonemal | 9.19e-06 | 17 | 147 | 4 | 536 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.80e-05 | 7 | 147 | 3 | 1113 | |
| GeneFamily | 14-3-3 phospho-serine/phospho-threonine binding proteins | 1.80e-05 | 7 | 147 | 3 | 1053 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | SPTBN1 SPTBN2 AFAP1L2 GRK3 ARHGEF9 OSBPL5 PLEKHH2 PRKD2 PLEKHG4B | 4.82e-05 | 206 | 147 | 9 | 682 |
| GeneFamily | Ankyrin repeat domain containing | ANKRD49 BARD1 POTEE OSBPL1A ANKS1A POTEF ANKRD62 POTEJ POTEI | 1.65e-04 | 242 | 147 | 9 | 403 |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 7.23e-04 | 50 | 147 | 4 | 1293 | |
| GeneFamily | Keratins, type II | 1.33e-03 | 27 | 147 | 3 | 609 | |
| GeneFamily | BEN domain containing | 2.28e-03 | 9 | 147 | 2 | 422 | |
| GeneFamily | C2 domain containing protein kinases | 2.83e-03 | 10 | 147 | 2 | 835 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 4.11e-03 | 12 | 147 | 2 | 670 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CALCOCO2 USP34 MYCBP2 HIPK1 SPEF2 ACTB ANKRD49 DAXX ITGAE ITGB7 PDCD4 ITPKB LAPTM5 UBR5 CCSER2 DIAPH1 TASOR DOCK2 PRKD2 NSD1 YTHDC2 YWHAB BTN3A2 PPM1B MSN PPP4R3B GIMAP8 PPT1 LNPEP EIF4A2 PDE4DIP SMARCA2 MTR PRKCB SNTB2 | 2.41e-08 | 1492 | 217 | 35 | M40023 |
| Coexpression | SASSON_RESPONSE_TO_FORSKOLIN_DN | 5.40e-07 | 85 | 217 | 8 | M12924 | |
| Coexpression | SASSON_RESPONSE_TO_GONADOTROPHINS_DN | 7.47e-06 | 86 | 217 | 7 | M17143 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | AUH MYCBP2 BARD1 NCK1 FAT1 DST MDN1 UBR5 CCSER2 TASOR RAB6A DOP1B ANKS1A PPM1B SMARCA2 | 8.80e-06 | 466 | 217 | 15 | M13522 |
| Coexpression | KRAS.300_UP.V1_DN | 2.27e-05 | 140 | 217 | 8 | M2874 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | CENPN SPTA1 ACTBL2 SPTBN1 EMILIN2 BARD1 NCK1 EDC4 ITGA9 DNAH14 POTEE DST CEP120 POTEF POTEJ POTEI | 3.19e-05 | 584 | 217 | 16 | MM1080 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 AUH MYCBP2 BARD1 NCK1 MAST2 FAT1 DST MDN1 UBR5 CCSER2 SETD3 SUCO TASOR RAB6A DOP1B ANKS1A PPM1B SMARCA2 MTR | 3.23e-05 | 856 | 217 | 20 | M4500 |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_DN | 4.65e-05 | 200 | 217 | 9 | M7508 | |
| Coexpression | GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_DN | BARD1 TATDN2 CYFIP1 SCN8A SNRNP40 ARHGEF28 CIP2A RFC5 NECAB3 | 4.65e-05 | 200 | 217 | 9 | M3051 |
| Coexpression | KIM_ALL_DISORDERS_CALB1_CORR_UP | AUH MYCBP2 SNX17 NARS1 ACTN1 RYR2 ARHGEF9 OSBPL1A SNRNP40 HSP90AB1 KALRN YWHAB GSTA4 EIF4A2 GABRA5 | 5.60e-05 | 547 | 217 | 15 | M2110 |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN | 7.24e-05 | 122 | 217 | 7 | M6677 | |
| ToppCell | CTRL-Myeloid|CTRL / Disease state, Lineage and Cell class | RNF130 EMILIN2 ACTN1 LAPTM5 DST GRK3 KCNE1 DOCK2 TFRC MSN PPT1 | 4.23e-09 | 199 | 217 | 11 | 70b89a930709fdb91fde6f96106add8455b11618 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | ACTA2 ACTC1 ACTG2 ACTN1 FAT1 AFAP1L2 SEMA6D PLCL1 ISYNA1 ARHGEF25 ATP1A4 | 4.46e-09 | 200 | 217 | 11 | b5b5a32925f225610fe25a021a742d6397162863 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | ACTA2 ACTC1 ACTG2 ACTN1 RYR2 FAT1 KRT77 PLCL1 ISYNA1 ARHGEF25 ATP1A4 | 4.46e-09 | 200 | 217 | 11 | c06426f877919bdd267ea2fd7e7973c6619832ae |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | ACTA2 ACTC1 ACTG2 ACTN1 RYR2 FAT1 SEMA6D KRT77 ISYNA1 PPFIA2 ATP1A4 | 4.46e-09 | 200 | 217 | 11 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-08 | 184 | 217 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-08 | 184 | 217 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-08 | 184 | 217 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SPTBN2 RYR2 ITPKA SCN8A KALRN PPFIA3 NECAB3 PRKCG RNF207 RAPGEFL1 | 4.00e-08 | 193 | 217 | 10 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SPTBN2 RYR2 ITPKA SCN8A KALRN PPFIA3 NECAB3 PRKCG RNF207 RAPGEFL1 | 4.00e-08 | 193 | 217 | 10 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SPTBN2 RYR2 ITPKA SCN8A KALRN PPFIA3 NECAB3 PRKCG RNF207 RAPGEFL1 | 4.00e-08 | 193 | 217 | 10 | 0c652ebe22ce5d2927599dd97ef1920547858395 |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | ACTA2 ACTC1 ACTG2 ACTN1 RYR2 FAT1 KRT77 ISYNA1 ARHGEF25 ATP1A4 | 5.60e-08 | 200 | 217 | 10 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type | ACTA2 ACTC1 ACTG2 ACTN1 RYR2 FAT1 KRT77 ISYNA1 ARHGEF25 ATP1A4 | 5.60e-08 | 200 | 217 | 10 | b0866b497aa71d06cef25f9a335fa584e95fa7e0 |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | ACTA2 ACTC1 ACTG2 ACTN1 RYR2 FAT1 KRT77 ISYNA1 ARHGEF25 ATP1A4 | 5.60e-08 | 200 | 217 | 10 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ACTA2 ACTC1 ACTG2 ACTN1 FAT1 KRT77 PLCL1 ISYNA1 ARHGEF25 ATP1A4 | 5.60e-08 | 200 | 217 | 10 | a3a1e35934d676c39f917652e50c502cb2f613c1 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | ACTA2 ACTG2 ACTN1 ITGA9 FAT1 DST HSP90AB1 ARHGEF25 ATP1A4 LONRF2 | 5.60e-08 | 200 | 217 | 10 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Mast|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.84e-08 | 151 | 217 | 9 | 9702575e47ececcf0a9f0f20a4a920dbb1ba5657 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.84e-08 | 151 | 217 | 9 | 673e4ab117b723c14d1df3804bbedc9e48284a9d | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Mast|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | FAM184B CYP11A1 RPS6KA1 EMILIN2 ITGB7 LAPTM5 KRT79 RGS18 PRKCB | 9.60e-08 | 160 | 217 | 9 | 6393e3d5c5c8176c93aecd89b313bd054a00d474 |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | FAM184B CYP11A1 RPS6KA1 EMILIN2 ITGB7 LAPTM5 KRT79 RGS18 PRKCB | 9.60e-08 | 160 | 217 | 9 | 2065938e944eb99478fd8132c2c03adeaee6d447 |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD141+_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.31e-07 | 166 | 217 | 9 | 9f14e3ef19d5903278c040be1c477501237173fa | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|kidney / Disease (COVID-19 only), tissue and cell type | 1.75e-07 | 124 | 217 | 8 | d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.15e-07 | 184 | 217 | 9 | 6e17c8151d6dc543de16d804db956c63c3fda414 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-07 | 185 | 217 | 9 | a2cae8c657e4f4d121476798e424876f7e247973 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-07 | 185 | 217 | 9 | d50406a9a5b8d75110ba5985741aa2293950c543 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-07 | 186 | 217 | 9 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 4.31e-07 | 191 | 217 | 9 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 5.13e-07 | 195 | 217 | 9 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 5.13e-07 | 195 | 217 | 9 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-07 | 196 | 217 | 9 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-07 | 196 | 217 | 9 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.36e-07 | 196 | 217 | 9 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.59e-07 | 197 | 217 | 9 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| ToppCell | lymphoid-T_cell-CD8+_Naive_T_cell|T_cell / Lineage, cell class and subclass | 6.08e-07 | 199 | 217 | 9 | 9ee40563e840a7fe97e7592539d42e19db438c64 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 6.34e-07 | 200 | 217 | 9 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 6.34e-07 | 200 | 217 | 9 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 6.34e-07 | 200 | 217 | 9 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 6.34e-07 | 200 | 217 | 9 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.34e-07 | 200 | 217 | 9 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.34e-07 | 200 | 217 | 9 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.74e-07 | 153 | 217 | 8 | 9c6fce56300ba5053efda59a438d63a808c497c0 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-06 | 159 | 217 | 8 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-06 | 159 | 217 | 8 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.61e-06 | 166 | 217 | 8 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.61e-06 | 166 | 217 | 8 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-06 | 168 | 217 | 8 | f150beee37e0252951a88adcd9e3f0a22e5cfdd9 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 169 | 217 | 8 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.20e-06 | 173 | 217 | 8 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.20e-06 | 173 | 217 | 8 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.20e-06 | 173 | 217 | 8 | f66aebceb3eb389bc5ff6c0b398d6f4e9959a14f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 2.50e-06 | 176 | 217 | 8 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-06 | 182 | 217 | 8 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-06 | 182 | 217 | 8 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.34e-06 | 183 | 217 | 8 | 9c66a40c355387f805dbdca4162dd05af5c1d8d4 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.34e-06 | 183 | 217 | 8 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.47e-06 | 184 | 217 | 8 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.47e-06 | 184 | 217 | 8 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.47e-06 | 184 | 217 | 8 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | Myeloid-D_(Mast_cell)|World / shred on cell class and cell subclass (v4) | 3.52e-06 | 130 | 217 | 7 | 574e262eb4ed2d69c3da68be061cebac9fefc29e | |
| ToppCell | megakaryocytic-Megakaryocyte|World / Lineage and Cell class | 3.76e-06 | 186 | 217 | 8 | acd15a169b6122b28cc99ef34de10701edcfedfe | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.76e-06 | 186 | 217 | 8 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.92e-06 | 187 | 217 | 8 | 34cad5ac8602fe88ca3d421257190c9a388d4cb0 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 4.07e-06 | 188 | 217 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 4.24e-06 | 189 | 217 | 8 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 4.40e-06 | 190 | 217 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.40e-06 | 190 | 217 | 8 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.58e-06 | 191 | 217 | 8 | b55500eb416f4f339031acad16b2737e5b891d8e | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature_-_proliferative|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.75e-06 | 136 | 217 | 7 | 96370f0e3abf1c9ec7a91595b5d0f97ac2ab4b78 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.33e-06 | 195 | 217 | 8 | 81a28289eda1a8a1a31b7357106f64ac5000e172 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.33e-06 | 195 | 217 | 8 | 1d58585557bf8e9ce4d514e128d3a902b526331d | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.33e-06 | 195 | 217 | 8 | eb2003d4f15cad213d17eda8ab7479f5a0c62164 | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 5.53e-06 | 196 | 217 | 8 | a753d76d764c181eecb0e17a794a2e7d0ff70136 | |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.53e-06 | 196 | 217 | 8 | 67400193ba469cf4d939e94f5ed94995e384bc07 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37|World / Primary Cells by Cluster | 5.75e-06 | 197 | 217 | 8 | 00d756bc0231e1b3b88430214338c1059cb11106 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 5.75e-06 | 197 | 217 | 8 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-06 | 197 | 217 | 8 | dea1d29154c585ab588e50b83c7c8de7fe24d2d4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.75e-06 | 197 | 217 | 8 | 8c24ffcd417da42fa9bcbe6bd0325360e537303f | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.75e-06 | 197 | 217 | 8 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.75e-06 | 197 | 217 | 8 | 5f6fce382f273e789ffbb75b63e9b4e87519918e | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 5.75e-06 | 197 | 217 | 8 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-06 | 197 | 217 | 8 | 72cd61b868d57862ec9c230ea68913d3829b0f2b | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 5.96e-06 | 198 | 217 | 8 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.96e-06 | 198 | 217 | 8 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 5.96e-06 | 198 | 217 | 8 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.19e-06 | 199 | 217 | 8 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | Mild_COVID-19-Myeloid-TRAM3|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 6.19e-06 | 199 | 217 | 8 | 4ab5da8ab757e8294c743949a5374b6e6a388913 | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM3|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.19e-06 | 199 | 217 | 8 | bae7aa25f9e23fea19371390b8306e9dc3e4d549 | |
| ToppCell | BAL-Mild-Myeloid-TRAM|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.19e-06 | 199 | 217 | 8 | 8a31a459491aa8625802c5211d38d57c1e8be76b | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.19e-06 | 199 | 217 | 8 | 4e518651ff219e163cfd9deb58566df6308aa3f7 | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM3-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.19e-06 | 199 | 217 | 8 | af167e7a16c3537ce0aa821f608cdcb0c3abc07f | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM3-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.19e-06 | 199 | 217 | 8 | 4b88ce864dc75ed8596a076ce4498f73639bbac8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.19e-06 | 199 | 217 | 8 | 0a9783808528bc4c6d797d849a9177330c8fb867 | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.42e-06 | 200 | 217 | 8 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.42e-06 | 200 | 217 | 8 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Biopsy_IPF-Epithelial-Basal|Biopsy_IPF / Sample group, Lineage and Cell type | 6.42e-06 | 200 | 217 | 8 | 5cea84581201cee7ba8141b96e65864f4fd67113 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.42e-06 | 200 | 217 | 8 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.42e-06 | 200 | 217 | 8 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.42e-06 | 200 | 217 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 6.42e-06 | 200 | 217 | 8 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.42e-06 | 200 | 217 | 8 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.42e-06 | 200 | 217 | 8 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| Drug | plakin | SPTA1 ACTBL2 SPTBN1 SPTBN2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 DST SNTB2 | 1.71e-11 | 82 | 215 | 12 | CID000018752 |
| Drug | Nsc687160 | 1.77e-10 | 18 | 215 | 7 | CID005459290 | |
| Drug | azaspiracid | 2.72e-10 | 30 | 215 | 8 | CID006451158 | |
| Drug | tolytoxin | 2.78e-10 | 19 | 215 | 7 | CID006440827 | |
| Drug | NSC312786 | 6.31e-10 | 21 | 215 | 7 | CID000329495 | |
| Drug | AC1L8NVR | 6.31e-10 | 21 | 215 | 7 | CID000384633 | |
| Drug | 1,N6-ethenoadenosine 5'-diphosphate | 8.16e-10 | 34 | 215 | 8 | CID000001312 | |
| Drug | AC1L1ERT | 9.57e-10 | 69 | 215 | 10 | CID000002920 | |
| Drug | trifluoperazine | SPTA1 ACTBL2 SPTBN1 SPTBN2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 ITGA9 GRK3 KCNE1 MYO3B ALOX12 PRKD2 PRKCB PRKCG | 2.06e-09 | 324 | 215 | 18 | CID000005566 |
| Drug | fasudil | TPO ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 GRK3 PRKD2 MTR PRKCB PRKCG | 2.10e-09 | 151 | 215 | 13 | CID000003547 |
| Drug | dihydrocytochalasin B | 3.60e-09 | 58 | 215 | 9 | CID000003064 | |
| Drug | epsilon-ATP | 4.06e-09 | 41 | 215 | 8 | CID000162262 | |
| Drug | D-myo-inositol 1,4-bisphosphate | 8.66e-09 | 86 | 215 | 10 | CID000000805 | |
| Drug | NpCaM | 1.51e-08 | 48 | 215 | 8 | CID000122259 | |
| Drug | m2-19 | 1.62e-08 | 19 | 215 | 6 | CID000079129 | |
| Drug | ML-9 | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 ITGA9 SNRNP40 PRKD2 PRKCB PRKCG | 1.62e-08 | 147 | 215 | 12 | CID000004217 |
| Drug | AC1L1HS4 | 1.67e-08 | 32 | 215 | 7 | CID000004267 | |
| Drug | N,N'-p-phenylenedimaleimide | 2.63e-08 | 34 | 215 | 7 | CID000076765 | |
| Drug | 3-methylhistidine | 4.62e-08 | 55 | 215 | 8 | CID000064969 | |
| Drug | AC1OAGFB | RNF130 SPTA1 ACTBL2 SPTBN1 SPTBN2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 CDH23 ACTG2 GRK3 KCNE1 RAB6A PRKD2 RPH3A TFRC MSN PRKCB PRKCG | 4.75e-08 | 539 | 215 | 21 | CID006857345 |
| Drug | beryllium fluoride | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 ITGA9 HSP90AB1 ABCC6 | 5.02e-08 | 103 | 215 | 10 | CID000024589 |
| Drug | AC1L1BDQ | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 GRK3 SNRNP40 PRKD2 PRKCB PRKCG | 9.91e-08 | 173 | 215 | 12 | CID000001394 |
| Drug | 0-to | RNF130 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 PRKD2 PRKCB PRKCG | 1.04e-07 | 141 | 215 | 11 | CID000002051 |
| Drug | dihydrosphingosine | SPTA1 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 PRKD2 PRKCB PRKCG | 1.48e-07 | 146 | 215 | 11 | CID000003126 |
| Drug | blebbistatin | 1.56e-07 | 116 | 215 | 10 | CID003476986 | |
| Drug | B0683 | 1.69e-07 | 117 | 215 | 10 | CID006398969 | |
| Drug | AC1L8FNU | 1.73e-07 | 44 | 215 | 7 | CID000425429 | |
| Drug | AC1NRCMD | 1.84e-07 | 90 | 215 | 9 | CID005289074 | |
| Drug | 5-IAF | 1.99e-07 | 66 | 215 | 8 | CID000123822 | |
| Drug | AC1L22RD | 2.03e-07 | 91 | 215 | 9 | CID000065183 | |
| Drug | CID5288653 | 2.09e-07 | 28 | 215 | 6 | CID005288653 | |
| Drug | C18:1n-7 | 2.23e-07 | 92 | 215 | 9 | CID000122325 | |
| Drug | NSC611747 | RPS6KA1 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 ACTN1 GRK3 MYO3B PRKD2 PPM1B MSN PRKCB PRKCG | 2.64e-07 | 352 | 215 | 16 | CID000002534 |
| Drug | caged ATP | 3.17e-07 | 70 | 215 | 8 | CID000123806 | |
| Drug | AC1Q6LQU | 3.22e-07 | 48 | 215 | 7 | CID000072380 | |
| Drug | C3H2N2O3S | 4.90e-07 | 74 | 215 | 8 | CID000448652 | |
| Drug | AC1LD8HW | 5.44e-07 | 75 | 215 | 8 | CID000644061 | |
| Drug | AC1L1KMJ | SPTA1 ACTBL2 SPTBN1 SPTBN2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 ACTN1 DST GRK3 KCNE1 PRKD2 MSN PRKCB PRKCG | 6.95e-07 | 476 | 215 | 18 | CID000030956 |
| Drug | 5'IATR | 7.48e-07 | 19 | 215 | 5 | CID000074997 | |
| Drug | 5'-N-ethylcarboxamidoadenosine | ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 GRK3 PRKD2 SMARCA2 PRKCB PRKCG | 8.63e-07 | 174 | 215 | 11 | CID000104795 |
| Drug | AC1NSKFN | 1.02e-06 | 36 | 215 | 6 | CID005311324 | |
| Drug | candesartan cilexetil | 1.24e-06 | 145 | 215 | 10 | CID000002540 | |
| Drug | NSC107658 | TPO SPTA1 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 MYO3B PRKD2 ARHGEF25 PRKCB PRKCG | 1.39e-06 | 306 | 215 | 14 | CID000002919 |
| Drug | fluorescein isothiocyanate | CYP11A1 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 TFRC TMEM132D | 1.41e-06 | 147 | 215 | 10 | CID000018730 |
| Drug | D-triiodothyronine | TPO ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 TOMM70 MYO3B PRKD2 GSTA4 THRB TMEM132D PRKCB PRKCG | 1.91e-06 | 409 | 215 | 16 | CID000000861 |
| Drug | oryzalin | 2.15e-06 | 63 | 215 | 7 | CID000029393 | |
| Drug | triphosphoinositide | RNF130 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 GRK3 KCNE1 PRKD2 TFRC PRKCB PRKCG | 2.15e-06 | 273 | 215 | 13 | CID009543520 |
| Drug | bistheonellide A | 2.42e-06 | 11 | 215 | 4 | CID006441172 | |
| Drug | Viroisin | 2.42e-06 | 11 | 215 | 4 | CID000119538 | |
| Drug | Rp-cAMPS | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 GRK3 PRKD2 PRKCB PRKCG | 2.51e-06 | 194 | 215 | 11 | CID006426631 |
| Drug | mDia | 2.84e-06 | 93 | 215 | 8 | CID000128346 | |
| Drug | manidipine | 3.34e-06 | 95 | 215 | 8 | CID000004008 | |
| Drug | losartan | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 ITGA9 ITGAE ITGB7 DST PRKD2 ABCC6 PRKCB PRKCG | 3.39e-06 | 378 | 215 | 15 | CID000003961 |
| Drug | BFDGE | 3.61e-06 | 12 | 215 | 4 | CID000091511 | |
| Drug | quinacrine | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 PLCL1 ALOX12 PRKD2 PRKCB PRKCG | 3.68e-06 | 243 | 215 | 12 | CID000000237 |
| Drug | AC1L1JYL | MYCBP2 SPTA1 PDZK1 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 ACTN1 GRK3 DOCK2 PRKD2 PRKCB PRKCG | 4.08e-06 | 434 | 215 | 16 | CID000005262 |
| Drug | NSC613009 | 4.14e-06 | 130 | 215 | 9 | CID000003800 | |
| Drug | AC1LADJ6 | 4.14e-06 | 130 | 215 | 9 | CID000486032 | |
| Drug | (2S,3R)-Sphingosine | SPTA1 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 ACTN1 RYR2 GRK3 KRT77 PRKD2 PRKCB PRKCG | 4.79e-06 | 389 | 215 | 15 | CID000001104 |
| Drug | AC1NRBPQ | 6.37e-06 | 137 | 215 | 9 | CID005288569 | |
| Drug | etheno-NAD | 6.57e-06 | 104 | 215 | 8 | CID005288160 | |
| Drug | kabiramide C | 7.19e-06 | 14 | 215 | 4 | CID005288658 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | RNF130 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 RYR2 ITPKA ITPKB GRK3 ST3GAL6 PLCL1 PRKD2 ITPKC PRKCB PRKCG | 8.23e-06 | 568 | 215 | 18 | CID000000806 |
| Drug | NSC106399 | 8.35e-06 | 51 | 215 | 6 | CID000002887 | |
| Drug | hypericin | 8.70e-06 | 108 | 215 | 8 | CID005281051 | |
| Drug | DE gel | 9.02e-06 | 143 | 215 | 9 | CID000008146 | |
| Drug | PRODAN | 9.73e-06 | 15 | 215 | 4 | CID000028127 | |
| Drug | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 GRK3 ALOX12 PRKD2 TMEM132D PRKCB PRKCG | 9.84e-06 | 314 | 215 | 13 | CID000003542 |
| Drug | AC1L9EF8 | 9.89e-06 | 79 | 215 | 7 | CID000443315 | |
| Drug | Ro-1724 | 9.96e-06 | 110 | 215 | 8 | CID000005087 | |
| Drug | NSC 523214 | 1.13e-05 | 147 | 215 | 9 | CID000004752 | |
| Drug | NSC-351907 | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 GRK3 PRKD2 PRKCB PRKCG | 1.22e-05 | 229 | 215 | 11 | CID000004016 |
| Drug | 6-propionyl-2-(dimethylamino)naphthalene | 1.29e-05 | 16 | 215 | 4 | CID000107729 | |
| Drug | phenylarsine oxide | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 GRK3 PRKD2 TFRC PRKCB PRKCG | 1.29e-05 | 275 | 215 | 12 | CID000004778 |
| Drug | HU-211 | 1.30e-05 | 114 | 215 | 8 | CID000107778 | |
| Drug | carbodiimide | 1.40e-05 | 151 | 215 | 9 | CID000009864 | |
| Drug | MAPS | SPTA1 ACTBL2 SPTBN1 SPTBN2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 | 1.45e-05 | 191 | 215 | 10 | CID000066161 |
| Drug | formamide | 1.61e-05 | 85 | 215 | 7 | CID000000713 | |
| Drug | phosphatidate | ACTBL2 SPTBN2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 GRK3 OSBPL1A ALOX12 PRKD2 ISYNA1 PRKCB PRKCG | 1.66e-05 | 432 | 215 | 15 | CID005460104 |
| Drug | Co-protoporphyrin IX | 1.67e-05 | 118 | 215 | 8 | CID000004972 | |
| Drug | Pb m | 1.67e-05 | 118 | 215 | 8 | CID006327255 | |
| Drug | Formyl | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 PRKD2 MTR PRKCB PRKCG | 1.75e-05 | 238 | 215 | 11 | CID000123370 |
| Drug | Doxazosin mesylate [77883-43-3]; Up 200; 7.4uM; HL60; HT_HG-U133A | SPTA1 SPTBN1 ACTC1 ACTG2 SEMA6D CCSER2 YTHDC2 RAB6B CIDEC PDE4DIP | 1.90e-05 | 197 | 215 | 10 | 3024_UP |
| Drug | chlorpromazine | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 KCNE1 XPNPEP2 PPT1 | 1.90e-05 | 197 | 215 | 10 | CID000002726 |
| Drug | enantio-PAF-C16 | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 ALOX12 PRKD2 PRKCB PRKCG | 2.20e-05 | 244 | 215 | 11 | CID000002499 |
| Drug | Y-27632 | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 ITGA9 DST DIAPH1 PRKD2 ARHGEF25 MSN PRKCB PRKCG | 2.29e-05 | 444 | 215 | 15 | CID000005711 |
| Drug | AC1NSKHI | 2.38e-05 | 61 | 215 | 6 | CID005311358 | |
| Drug | AC1OAGGW | 2.46e-05 | 203 | 215 | 10 | CID006857364 | |
| Drug | 6-trans-leukotriene B4 | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 ALOX12 PRKD2 PRKCB PRKCG | 2.46e-05 | 247 | 215 | 11 | CID000000169 |
| Drug | AC1Q5THZ | RNF130 CYP11A1 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 GRK3 KCNE1 ALOX12 PRKD2 TMEM132D PRKCB PRKCG | 2.47e-05 | 502 | 215 | 16 | CID000001959 |
| Drug | glycerophosphoinositol | 2.62e-05 | 62 | 215 | 6 | CID000167572 | |
| Drug | NSC339663 | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 NCK1 ACTN1 MYO3B SYCP1 | 2.75e-05 | 250 | 215 | 11 | CID000003892 |
| Drug | 2C5P | 2.84e-05 | 127 | 215 | 8 | CID000447961 | |
| Drug | AC1L1GXW | 3.10e-05 | 94 | 215 | 7 | CID000003891 | |
| Drug | AC1L1GZB | 3.11e-05 | 167 | 215 | 9 | CID000003908 | |
| Drug | bumetanide | 3.15e-05 | 209 | 215 | 10 | CID000002471 | |
| Drug | wiskostatin | 3.18e-05 | 39 | 215 | 5 | CID000448668 | |
| Drug | AC1L1IZ2 | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 RYR2 ITPKA GRK3 MYO3B RFC5 | 3.46e-05 | 304 | 215 | 12 | CID000004795 |
| Drug | AGEPC | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 SNRNP40 ALOX12 PRKD2 PRKCB PRKCG GABRA5 | 3.67e-05 | 356 | 215 | 13 | CID000461545 |
| Drug | NSC3096 | 4.06e-05 | 98 | 215 | 7 | CID000002832 | |
| Disease | Moyamoya disease (implicated_via_orthology) | 4.73e-18 | 8 | 205 | 8 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 4.73e-18 | 8 | 205 | 8 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 4.73e-18 | 8 | 205 | 8 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 4.73e-18 | 8 | 205 | 8 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 2.10e-16 | 10 | 205 | 8 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 2.10e-16 | 10 | 205 | 8 | DOID:13832 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome | 4.80e-05 | 2 | 205 | 2 | cv:C1853623 | |
| Disease | Spinocerebellar ataxia 14 | 4.80e-05 | 2 | 205 | 2 | C1854369 | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 4.80e-05 | 2 | 205 | 2 | C1855722 | |
| Disease | Fryns-Aftimos Syndrome | 4.80e-05 | 2 | 205 | 2 | C1853623 | |
| Disease | Spinocerebellar Ataxia Type 2 | 8.91e-05 | 34 | 205 | 4 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 8.91e-05 | 34 | 205 | 4 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 8.91e-05 | 34 | 205 | 4 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 8.91e-05 | 34 | 205 | 4 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 8.91e-05 | 34 | 205 | 4 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 8.91e-05 | 34 | 205 | 4 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 4 | 1.00e-04 | 35 | 205 | 4 | C0752122 | |
| Disease | neuroblastoma | 1.64e-04 | 116 | 205 | 6 | EFO_0000621 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 2.86e-04 | 4 | 205 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | hormone measurement | 3.05e-04 | 84 | 205 | 5 | EFO_0004730 | |
| Disease | Tinnitus | 3.05e-04 | 130 | 205 | 6 | HP_0000360 | |
| Disease | Liver Cirrhosis, Experimental | GLT8D1 ACTA2 ACTN1 CIDEA LAPTM5 SNAP29 FAT1 SEMA6D ISYNA1 KRT19 MAP3K8 XPNPEP2 MSN PRKCB TRAK2 | 3.61e-04 | 774 | 205 | 15 | C0023893 |
| Disease | Profound Mental Retardation | 4.36e-04 | 139 | 205 | 6 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 4.36e-04 | 139 | 205 | 6 | C0025363 | |
| Disease | Mental deficiency | 4.36e-04 | 139 | 205 | 6 | C0917816 | |
| Disease | Adenoid Cystic Carcinoma | 6.80e-04 | 100 | 205 | 5 | C0010606 | |
| Disease | Uveoretinal Coloboma | 9.86e-04 | 7 | 205 | 2 | C4554007 | |
| Disease | response to corticosteroid | 1.06e-03 | 29 | 205 | 3 | GO_0031960 | |
| Disease | hearing loss | 1.23e-03 | 67 | 205 | 4 | EFO_0004238 | |
| Disease | nemaline myopathy (implicated_via_orthology) | 1.31e-03 | 8 | 205 | 2 | DOID:3191 (implicated_via_orthology) | |
| Disease | Myocardial Ischemia | 1.49e-03 | 176 | 205 | 6 | C0151744 | |
| Disease | retinal degeneration (implicated_via_orthology) | 1.55e-03 | 33 | 205 | 3 | DOID:8466 (implicated_via_orthology) | |
| Disease | telomere length | 1.63e-03 | 313 | 205 | 8 | EFO_0004505 | |
| Disease | Congenital ocular coloboma (disorder) | 1.67e-03 | 9 | 205 | 2 | C0009363 | |
| Disease | breast cancer (is_marker_for) | 1.92e-03 | 185 | 205 | 6 | DOID:1612 (is_marker_for) | |
| Disease | Bipolar Disorder | 1.96e-03 | 477 | 205 | 10 | C0005586 | |
| Disease | vesicular integral-membrane protein VIP36 measurement | 2.08e-03 | 10 | 205 | 2 | EFO_0022012 | |
| Disease | 1,7-dimethylurate measurement | 2.08e-03 | 10 | 205 | 2 | EFO_0021512 | |
| Disease | Congenital neurologic anomalies | 2.08e-03 | 10 | 205 | 2 | C0497552 | |
| Disease | Cranioschisis | 2.08e-03 | 10 | 205 | 2 | C0265541 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 2.08e-03 | 10 | 205 | 2 | C1631597 | |
| Disease | Developmental delay (disorder) | 2.16e-03 | 37 | 205 | 3 | C0424605 | |
| Disease | asthma | SPEF2 ITPKA ITPKB PLCL1 TASOR MAP3K8 NAALADL2 TFRC PLEKHG4B THRB TMEM132D ZNF665 SMARCA2 | 2.41e-03 | 751 | 205 | 13 | MONDO_0004979 |
| Disease | Copper-Overload Cirrhosis | 2.54e-03 | 11 | 205 | 2 | C1876165 | |
| Disease | pericalcarine cortex volume measurement | 2.54e-03 | 11 | 205 | 2 | EFO_0010322 | |
| Disease | Cognitive impairment | 2.54e-03 | 11 | 205 | 2 | HP_0100543 | |
| Disease | Long QT Syndrome | 2.54e-03 | 11 | 205 | 2 | C0023976 | |
| Disease | response to selective serotonin reuptake inhibitor | 2.59e-03 | 82 | 205 | 4 | EFO_0005658 | |
| Disease | Inherited neuropathies | 2.70e-03 | 40 | 205 | 3 | C0598589 | |
| Disease | Autism Spectrum Disorders | 2.95e-03 | 85 | 205 | 4 | C1510586 | |
| Disease | niacinamide measurement | 3.03e-03 | 12 | 205 | 2 | EFO_0010511 | |
| Disease | Gastrointestinal Diseases | 3.03e-03 | 12 | 205 | 2 | C0017178 | |
| Disease | Functional Gastrointestinal Disorders | 3.03e-03 | 12 | 205 | 2 | C0559031 | |
| Disease | Cholera Infantum | 3.03e-03 | 12 | 205 | 2 | C1565321 | |
| Disease | age at menarche | USP34 NXPE2 DST SEMA6D SNX32 PLCL1 CPA5 MYO1H YWHAB THRB SMARCA2 | 3.09e-03 | 594 | 205 | 11 | EFO_0004703 |
| Disease | Autoimmune Diseases | 3.11e-03 | 42 | 205 | 3 | C0004364 | |
| Disease | subiculum volume | 3.32e-03 | 43 | 205 | 3 | EFO_0009399 | |
| Disease | illegal drug consumption | 3.56e-03 | 13 | 205 | 2 | EFO_0005431 | |
| Disease | Malignant neoplasm of salivary gland | 3.78e-03 | 45 | 205 | 3 | C0220636 | |
| Disease | femoral neck bone geometry | 4.14e-03 | 14 | 205 | 2 | EFO_0004511 | |
| Disease | electrocardiography | MYCBP2 SPTBN1 ACTB KCNE1 PLCL1 POTEF YTHDC2 THRB ROS1 RNF207 | 4.14e-03 | 530 | 205 | 10 | EFO_0004327 |
| Disease | coronary artery disease | RPS6KA1 DHX38 EPB41L4A ITPKA AFAP1L2 CEP120 GRK3 PLCL1 PLEKHH2 DOCK6 ANKS1A PRKD2 LRRC40 LMNB2 RPH3A TMEM132D LNPEP | 4.23e-03 | 1194 | 205 | 17 | EFO_0001645 |
| Disease | Salivary Gland Neoplasms | 4.28e-03 | 47 | 205 | 3 | C0036095 | |
| Disease | QT interval | MAST2 ITPKA KCNE1 TASOR ARHGEF28 LMNB2 THRB ROS1 RNF207 PPP6R3 | 4.36e-03 | 534 | 205 | 10 | EFO_0004682 |
| Disease | Down syndrome (implicated_via_orthology) | 4.75e-03 | 15 | 205 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | response to antineoplastic agent | 5.09e-03 | 99 | 205 | 4 | GO_0097327 | |
| Disease | thyroid volume | 5.41e-03 | 16 | 205 | 2 | EFO_0004865 | |
| Disease | erythrocyte cadmium measurement | 6.10e-03 | 17 | 205 | 2 | EFO_0007807 | |
| Disease | Moyamoya Disease | 6.10e-03 | 17 | 205 | 2 | C0026654 | |
| Disease | reticulocyte count | USP34 RPS6KA1 SPTA1 SNX17 ACTB ACTN1 MAST2 FAT1 HSP90AB1 ARHGEF28 POTEF RPH3A TFRC GIMAP8 THRB | 6.57e-03 | 1045 | 205 | 15 | EFO_0007986 |
| Disease | congestive heart failure (biomarker_via_orthology) | 6.69e-03 | 107 | 205 | 4 | DOID:6000 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YGALVSEMKELRDLN | 221 | Q7L4P6 | |
| RTAEKMALTLLDYLF | 246 | Q8N9N5 | |
| EESYKDSTLIMQLLR | 211 | P62258 | |
| ESYKDSTLIMQLLRD | 211 | P31946 | |
| SLELLRLKDENYMIA | 196 | Q9BWT7 | |
| EKEMRFYATEIILGL | 291 | P35626 | |
| RSKLYDEESLLSLTM | 2111 | Q9HCK8 | |
| MLRQKDYETATLSEI | 416 | P12814 | |
| LAGDKNYITMDELRR | 836 | P12814 | |
| GEYSRKLEERFMTLA | 116 | Q8N998 | |
| KALERSMYVLSELVE | 156 | Q86VW2 | |
| VDYTDDESMKSLLLL | 531 | Q99728 | |
| VLRMRSLKGDADLYV | 66 | Q7Z4R8 | |
| DSYKDSTLIMQLLRD | 211 | P31947 | |
| AIMRLDLAGRDLTDY | 176 | P68133 | |
| DLAGRDLTDYLMKIL | 181 | P68133 | |
| DLTDYLMKILTERGY | 186 | P68133 | |
| LAGRDLTDYLMKILT | 181 | Q562R1 | |
| AGRELTDYLMKILTE | 181 | Q9BYX7 | |
| AGRDLTDYLMKILTE | 181 | P60709 | |
| AGRDLTDYLMKILTE | 181 | P63261 | |
| VAGLLKRLIEMTAEY | 311 | Q9H845 | |
| AIMRLDLAGRDLTDY | 176 | P62736 | |
| DLAGRDLTDYLMKIL | 181 | P62736 | |
| DLTDYLMKILTERGY | 186 | P62736 | |
| MERYKALEQLLTELD | 1 | Q8N4X5 | |
| ELILMKNGSSRLTEY | 81 | Q53H64 | |
| TDKRVGYLGAMLLLD | 81 | O75843 | |
| ISMARKLLAYGADIE | 151 | A6NC57 | |
| KDALLTYLEQVRMGI | 611 | Q96SM3 | |
| LAGRDLTDYLMKILT | 181 | P63267 | |
| RYSVALVLKEMADLE | 201 | Q9GZQ3 | |
| MNTEELELLSDSKYR | 1 | Q5JWR5 | |
| LDLAALYGRLEVVKM | 186 | Q92625 | |
| LGRDYLETLMASQKA | 606 | Q96G46 | |
| EDSYDLKGRLDDIRM | 371 | O60610 | |
| DTGLIMLIARLDYEL | 511 | Q9H251 | |
| SLAMSRLDEVISKYA | 366 | Q9UER7 | |
| DILDRSSELIYTGEM | 311 | O43307 | |
| FYMLTLDKDRIIDAG | 1996 | Q96L73 | |
| TGNLLLYEKLDREVM | 81 | Q9Y5E4 | |
| IGIDFLSKTMYLEDR | 46 | P20340 | |
| IGIDFLSKTMYLEDR | 46 | Q9NRW1 | |
| TRTDLKLSYLEEAVM | 1331 | Q6P2E9 | |
| MITELRGKDILSYLE | 156 | Q86XS8 | |
| KMGSRTYLEEELVKA | 486 | Q96DU7 | |
| DSKRALDEYTSELML | 391 | Q9NPH2 | |
| ARELGYSLEQRTVKM | 196 | Q9NWY4 | |
| SLLVVDKETDNMYRL | 316 | Q5T2W1 | |
| MKVDDSAYESLGLRP | 701 | O75808 | |
| RKQALMSEERTLLYD | 1076 | Q8N1W1 | |
| MYKSLELAIGRFESE | 776 | Q7L576 | |
| RIIKGEDMASTRYES | 81 | Q8WYQ4 | |
| LTGRLDYLETKLYEM | 206 | Q14517 | |
| AGRELPDYLMKILTE | 881 | A5A3E0 | |
| STLKILDLMEGRLLY | 251 | Q8NBT0 | |
| VSVILKSDLMYDRLS | 701 | Q5KSL6 | |
| KSDLMYDRLSVLIDV | 706 | Q5KSL6 | |
| YRMIKLGLGIDEDEV | 681 | P08238 | |
| LMDIKSRLEQEIATY | 366 | P08727 | |
| ESLEYVRGEISKAMA | 4461 | Q9NU22 | |
| NYMAEREDELSLIKG | 116 | P16333 | |
| GYSSEMKTEDELRVR | 66 | Q13825 | |
| MLAEKADRREYIDLL | 481 | Q86Z02 | |
| ELTHMEYDLEKRGIT | 3256 | Q03001 | |
| ELKEARMRLESLSYQ | 306 | Q03252 | |
| MEERITTLEKRYLSA | 301 | O75145 | |
| MNLLIDDIRSFKEYS | 456 | Q96MR6 | |
| VTLLVDRDGLYKMNR | 231 | Q2M2W7 | |
| LASLLDMVYRSDEKE | 1906 | Q9Y3R5 | |
| YRKLLESEESRMSGE | 446 | Q5XKE5 | |
| DDLKYTMIRLAVDGA | 986 | Q2LD37 | |
| TLSREMLELKADYER | 146 | Q9ULE4 | |
| KDYMITITRLLLGLD | 966 | Q5JUK3 | |
| MSVKLALDIEIATYR | 426 | P19013 | |
| DYGKDRVLTDILNAM | 216 | Q8WXQ8 | |
| DVMKSISLLRYQEES | 1226 | Q10570 | |
| DGLLSKLRYNIISME | 376 | P38570 | |
| EMLKRQRSLYIDLGA | 436 | P41279 | |
| YTSRDELMEERLTKS | 1116 | Q9P2D6 | |
| MDYSVGVLLRRAEKT | 541 | O43424 | |
| DLMYLLKAEDSARTL | 366 | Q8N3Y1 | |
| IDMLLKEYLLSGDIS | 331 | Q53EL6 | |
| ALHGKLEYLTDIMRT | 1411 | Q9ULL4 | |
| LEYLTDIMRTLLGDL | 1416 | Q9ULL4 | |
| SVLEESKRLVDTAMY | 41 | P07202 | |
| ERYSVGLLDMTKEKE | 271 | P35913 | |
| TSYILILELMDDGRL | 2751 | O60229 | |
| YTMVRLDCEDLKTGL | 466 | Q6ZR08 | |
| LRELEGKMGERYITH | 816 | Q9BZL6 | |
| KLGYMDLASRLVTRV | 781 | Q9UIQ6 | |
| IRDSADMVELLDGYT | 261 | Q96MU8 | |
| GMLREDAVLEYLKIA | 181 | P26038 | |
| KLLRLEDDGTLLYTM | 151 | P31644 | |
| MKLNVEEGLYSRTLA | 266 | Q68CQ7 | |
| VMLSERKGTDELYAV | 356 | P05771 | |
| GIIYRDLKLDNVMLD | 461 | P05771 | |
| MLAERRGSDELYAIK | 366 | P05129 | |
| KRIYDEEMSELSNLT | 521 | Q1L5Z9 | |
| DSKDTLELLLMNRYV | 186 | Q8WVL7 | |
| YESKRMGIIVRDEST | 546 | O75110 | |
| GALEMALKRVYTLLS | 181 | P18054 | |
| YVEELKGMSLLVRAE | 31 | Q5MIZ7 | |
| SYEELRSLLLGRSME | 431 | P78316 | |
| TGRKELVMLLLEYNA | 91 | Q9BXW6 | |
| ELLAMIFGYLDVRDK | 11 | Q8N1E6 | |
| RGETDREKLLLMYQT | 1226 | Q8IVE3 | |
| SYSMKDDLERVRQLG | 161 | P26010 | |
| LDCKMGVRTYLEEEL | 261 | P23677 | |
| AGRELPDYLMKILTE | 881 | Q6S8J3 | |
| TSLYTQDRLGLKEMD | 261 | P50897 | |
| SALAKEESRTIDIYM | 906 | Q13797 | |
| KMRYLSDDVDDISLS | 386 | Q9H7U1 | |
| LKERTLIDMYVEGTL | 86 | O15217 | |
| EVETGYLKSRSAMIL | 351 | O00471 | |
| LLEKLLDYRGVMTDE | 1181 | Q92608 | |
| RRSLKTILTYAEEDM | 1526 | Q96HP0 | |
| TLEDYGLVKMREIFI | 601 | Q8N960 | |
| GIMELTDTELILYTR | 36 | Q8WU20 | |
| LSDEMREDYLLSVRK | 206 | Q8WXX0 | |
| FEYMIILLTRKEDLG | 356 | Q8ND71 | |
| LIEQLRMEYKDSASL | 621 | Q3MJ40 | |
| DLLKRENSRLLSYMG | 336 | Q13137 | |
| MDLRSRYLDSLKAIV | 191 | Q96H22 | |
| ILYRLLGDSKMSFED | 301 | P05108 | |
| KEMGYAATEREISLR | 291 | P78410 | |
| ELDSIAMKIRYLTEQ | 2101 | Q0VDD8 | |
| DDMNLKESLLRGIYA | 36 | Q14240 | |
| KVYSSMERLSLLEER | 851 | Q6P0Q8 | |
| EEIYSMDEGIRTRSK | 886 | Q96P70 | |
| RSSDGKLEALYVLMV | 36 | P15382 | |
| AYVDSKIDALREELM | 316 | Q9BXX0 | |
| LIEQLRMEYKDSASL | 621 | A2RUR9 | |
| NLEKLYLASLRSMGE | 81 | Q9C0D2 | |
| MFYEGLKIARESLLR | 81 | O15431 | |
| EAELNYLRTAKSLEM | 191 | Q9HCS5 | |
| YGRDRISELLGMDKA | 4661 | Q92736 | |
| RMKELEDNLLYRLTS | 3756 | Q8TE73 | |
| MKGTAAILEYLRDRI | 586 | Q9H9A6 | |
| MEERITTLEKRYLSA | 336 | O75334 | |
| KTEMDKLSSGLDIYR | 16 | Q8NGG3 | |
| YILMTEGALDRESKA | 401 | Q9Y5E1 | |
| AAVEEDAYSRMKLVL | 416 | Q9H0X9 | |
| LYTDMRLTELAEVKR | 811 | Q9UPX6 | |
| LEGEMLYLELTARDA | 111 | P82980 | |
| LRLSLAEELSTYKAM | 441 | Q9H7C4 | |
| YRGESEKLVRLLFEM | 281 | Q9BW62 | |
| VSDRRLYLLKVTGEM | 831 | Q8N1F8 | |
| KAEFLDLGYELMERL | 306 | Q6ZRF8 | |
| LGERYLNEMASTEKL | 1396 | Q9C093 | |
| GDIEERGKILVSLMY | 546 | Q9Y2J0 | |
| DRLRDQGSTMIYLKA | 176 | Q93075 | |
| YRSLGDLEKDVMLLC | 1461 | P51531 | |
| KAYIMGLLDRLEVVS | 106 | Q9ULQ0 | |
| LIVDSRELGYLNKMD | 96 | Q96CG3 | |
| SMRIFDSEEILAGYK | 476 | O43776 | |
| IDRGMDFEESKYLLS | 991 | Q14C87 | |
| GLEKIATEDTRLIYM | 216 | Q8NDG6 | |
| KLSQMGYLRIADLIS | 51 | Q13571 | |
| LERKLIYLMGDSTLH | 356 | Q96DL1 | |
| DKLRSLLMYAFGLLE | 1061 | O95255 | |
| LLTKMADIEYRLSVG | 301 | P40937 | |
| AKTMETNREELYDLL | 651 | Q96NR3 | |
| MGIRTYLEEELTKAR | 746 | P27987 | |
| YSSIMVKALGDRLAE | 1121 | Q99707 | |
| LDLAGRELTDYLMKI | 841 | P0CG39 | |
| RELTDYLMKILTERG | 846 | P0CG39 | |
| AETGYMQRRLVKSLE | 866 | O14802 | |
| IIISASSDKRLYMGE | 341 | Q96DI7 | |
| SRSLALMYESEKVGV | 61 | O95721 | |
| SDRLYAMKAEVLARA | 346 | Q86TU7 | |
| TLGEKIDSYDVIIRM | 131 | Q9Y274 | |
| LRMKDNDLLVSELYR | 356 | Q8TBC3 | |
| EYARDVGLKTDLVTM | 191 | Q92186 | |
| LMRLEYEGLHKSEAI | 4506 | O75592 | |
| AGRELTDYLMKILTE | 881 | P0CG38 | |
| LEEMLTSYRLAKVEG | 411 | O75688 | |
| LGTTMDTYKELIERI | 566 | P02786 | |
| MEEVLTKLREDLELY | 356 | Q5VX52 | |
| TDLYTDLRDGRMLIK | 76 | Q01082 | |
| GRLDKELSESYAFLM | 171 | Q9UK61 | |
| AIMRLDLAGRDLTDY | 176 | P68032 | |
| DLAGRDLTDYLMKIL | 181 | P68032 | |
| DLTDYLMKILTERGY | 186 | P68032 | |
| ISLAYESAESDIMKR | 826 | Q13733 | |
| LGTYMLRVLDDKEER | 191 | O60543 | |
| DRSVRKGIMAYSLED | 51 | Q96AQ7 | |
| YSLEDLLLKVRDTLM | 61 | Q96AQ7 | |
| DGTLTRKYSVDLLMD | 246 | Q8TCG1 | |
| ESYDNRLLMGDERVK | 51 | Q86X95 | |
| MGEAFYTVKLERLES | 66 | Q9H7R5 | |
| LELAFEYLMSKDRLQ | 346 | Q15036 | |
| MTEELSGKSDELIRY | 266 | O60296 | |
| EMLSSDDGRIIVKYL | 301 | Q4W5G0 | |
| EYTMLRNIGLKTIDD | 871 | Q15111 | |
| VNALTLEDEKRMLSY | 621 | Q7Z3J2 | |
| LEDEKRMLSYLINGF | 626 | Q7Z3J2 | |
| RFLKSDIYLDLMEGR | 191 | Q9NS28 | |
| AEEFTYIMKRLGRAL | 1151 | P10745 | |
| MEAERLVEKYESLAS | 301 | O15020 | |
| TGGKMAYLLIEEDIR | 261 | Q9H147 | |
| LSMVSEEETLKTLYR | 901 | Q15431 | |
| RELGDKMDLASYLLR | 921 | Q96PX9 | |
| MAQYLTDILGDKLDL | 431 | O75038 | |
| YVGMATDLVLDDSKR | 171 | P10828 | |
| YDALDMLTRENVALK | 36 | Q6IQ55 | |
| LLVSMDQLASYGRKD | 681 | Q9UQD0 | |
| IDAEGKYMAEALLLR | 321 | O94826 | |
| ENTLIKYMTDGILLR | 621 | Q92620 | |
| KYMTDGILLRESLRE | 626 | Q92620 | |
| LELMEGGDLLTYLRK | 2026 | P08922 | |
| RGLKLEESLEYLQFM | 1811 | P02549 | |
| YSIGRRLDFELGKMI | 501 | Q9NZM6 | |
| RIKALEVNMSLSGRY | 921 | Q9UBS9 | |
| ASARLRKEEMGALYV | 1111 | O60290 | |
| KEMFLEDILRTTGYT | 376 | Q9H6S0 | |
| EDILRTTGYTNKEML | 381 | Q9H6S0 | |
| ELNRKLSSDEMYLLD | 436 | O43895 | |
| RAAAYDLLVEMVKGS | 1841 | Q70CQ2 | |
| TSKGKDDVYDRMLLD | 3126 | Q70CQ2 | |
| IMKDESLYQGLREDT | 251 | Q9UHV5 | |
| ERLKMSADDGIRNLY | 486 | Q13425 | |
| VASDEDLKLSDMLRY | 281 | Q86XE0 | |
| LMLKIRDTLYIAGRD | 61 | Q8NFY4 | |
| STVYSRMKEELAALI | 126 | Q86XT4 | |
| LGEDESLLMKLYSFL | 96 | Q5H9R7 | |
| YLRELLSAKDARGMT | 1101 | O95071 | |
| LRDYQAMLGVKLSLD | 446 | Q7Z794 | |
| YLVTELMRGGELLDK | 486 | Q15418 | |
| LELSVYARDAMAKAV | 336 | Q8N1T3 | |
| VIDVSYGMADDLKRI | 276 | Q58DX5 | |
| VMGARISEYLLEKSR | 506 | Q8WXR4 | |
| RLLCETSLGYKMDDL | 2076 | Q6PIF6 | |
| NELEKYRVMLTGESL | 1246 | Q5VU43 | |
| LAAMDATKLEYERAS | 121 | Q96P71 |